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1. Introduction 
bHLH-PAS transcription factors 
 The PAS domain was named after proteins in which this motif was present, 
namely Drosophila PERIOD (PER), mammalian aryl hydrocarbon receptor nuclear 
translocator (ARNT) and Drosophila Single-Minded (SIM) (Huang et al., 1993). The 
PAS domain appears to act as a dimerization motif (Huang et al., 1993) to interact 
with other members of the bHLH-PAS transcription factor family. PERIOD is found 
to be involved in regulating the circadian rhythm as mutations can cause lengthening 
or shortening of the circadian rhythm in Drosophila (Konopka and Benzer, 1971). 
Aryl hydrocarbon receptor (AhR) is also known as the dioxin receptor. Dioxins are a 
class of organic compounds which is considered as an environmental pollutant. AhR 
is activated when it binds to its ligand and regulates downstream genes with its 
heterodimer, ARNT. ARNT is thought to be a generic dimerization partner (Swanson 
et al., 1995) for bHLH-PAS domain proteins as it binds a host of other bHLH-PAS 
proteins like HIF-1α (Jiang et al., 96) and EPAS1 (Hogenesch et al., 1997). SIM was 
found to be essential for the development of Drosophila central nervous system 
midline cells (Nambu et al., 1991). As it can be seen bHLH-PAS proteins are 
involved in a range of important physiological events.  
Expression of NPAS1  
 Murine NPAS1 or neuronal PAS domain protein 1 is 595 amino acids long 
and it contains a bHLH domain with two PAS domains (PAS A & PAS B) and a PAS 
associated C-terminal motif (PAC). NPAS1 was first characterized in detail by (Zhou 
et al., 1997). Then it was found to be exclusively expressed in brain and spinal cord 
tissue by RNA blotting. It was shown by the same group that NPAS1 mRNA first 
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appeared between embryonic day 15 and 16. NPAS1 mRNA peaked at postnatal day 
3 (Zhou et al., 1997), this detail becomes significant when results from other 
experiments are considered. NPAS1 expression in the brain was also shown by 
immunohistochemistry (Ohsawa et al., 2005). Specifically, the expression was first 
seen in part of the cerebral cortex, olfactory bulb and hippocampus in E16.5. 
Additionally, NPAS1 was found to be expressed in liver by Western blotting (Teh et 
al., 2006). 
 NPAS1 was first investigated in our laboratory as it was isolated from 
subtractive hybridization and microarray studies on differentiated MN9D cells (Teh et 
al., 2006). MN9D cells are dopaminergic in nature (Choi et al., 1991) and further 
differentiation was undertaken by adding 1 mM sodium butyrate to the culture media.  
Butyrate was used as it was previously shown to differentiate PC12 cells (Byrd and 
Alho, 1987) (Ebert et al., 1997) and other neuroblastoma cells (Rocchi et al., 1992). 
NPAS1 was shown to be one of the genes that are upregulated (Teh et al., 2006). 
Butyrate is known to affect gene expression because of its ability to inhibit histone 
deacetylase. Butyrate is a short chain fatty acid which is found in the body 
physiologically. It is produced by bacterial fermentation in the colon. Butyrate can be 
metabolised by the human body, and can enter into the bloodstream (Pouteau et al., 
2003). After birth, one of the key events is bacterial colonisation of the gut 
(Ducluzeau, 1983) (Dai et al., 1999). Around this time, it is likely that the butyrate 
levels experience a sudden increase. Furthermore, it is known that butyrate can enter 
the bloodstream (Cummings et al., 1987). The bacterial colonisation of the gut and 
subsequent production of butyrate may coincide with an observed peak expression of 
NPAS1 at postnatal day 3 (Zhou et al., 1997) by mice. There is a delayed surge in the 
biosynthesis and release of catecholamines peaking at postnatal day 7-10 (Bannister 
and Mathias, 1992). This delay might be a result of the increased NPAS1 expression.  
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 Regulation of TH by butyrate is already established in literature. However, 
there are conflicting reports on butyrate's effect on TH. It was first established that 
butyrate has a dosage and gene specific effect on PC12 cells (Nankova et al., 2003). 1 
mM concentration of sodium butyrate increased proenkephalin and TH mRNA of 
PC12 cells after 48 hours. The same conditions were applied except that 6 mM 
concentration of sodium butyrate was used produced different results. There was still 
an increase in proenkephalin mRNA but the level of TH mRNA decreased below 
control levels. However, 6 mM of sodium butyrate for a duration of 24 hours is able 
to increase expression of a CAT reporter gene seven fold in PC12 cells through the rat 
TH promoter (-773/+27 bp) (Patel et al., 2005). Nevertheless, the consistent fact is at 
low levels of butyrate, TH is repressed. In contrast, overexpression of NPAS1 in 
MN9D cells was seen to repress TH expression (Teh et al., 2006a). NPAS1 up 
regulation appears to be a result of addition of 1 mM butyrate to culture media (Teh et 
al., 2006a). One plausible explanation might be differing sensitivity to butyrate for 
different cell types i.e. in MN9D, 1 mM of butyrate might be sufficient to repress TH 
levels through the up regulation of NPAS1. 
NPAS1 represses EPO and TH 
 The other known NPAS1 regulated gene is erythropoietin (EPO) (Ohsawa et 
al., 05). Overexpression of NPAS1 was shown to repress the level of EPO in SH-
SY5Y cells. The study also established that NPAS1 is able to bind ARNT in vivo. 
NPAS1 was also shown to bind the EPO enhancer region by chromatin 
immunoprecipitation in postnatal day 0 mice brain. In addition, the same study also 
proved that NPAS1 is able to repress hypoxia responsive element (HRE) driven 
expression of luciferase in HEK293 cells. The HRE is present in the regulatory region 
of many genes which are upregulated by the hypoxia inducible factor 1 (HIF-1) 
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transcription factor (Wenger et al., 2005) which is comprised of a heterodimer formed 
of HIF-1 alpha (HIF-1α) and HIF-1 beta (ARNT).  
 Tyrosine hydroxylase (TH) is one of the genes which is upregulated by HIF-1 
(Leclere et al., 2004). TH is the rate-limiting enzyme in the production of 
catecholamines, including dopamine. The ability of NPAS1 to repress HRE driven 
gene expression suggests that it may repress TH expression as well. This was shown 
by other members in our laboratory to be true. Overexpression of murine NPAS1 in 
MN9D cells resulted in a decrease in TH protein levels (Teh et al., 2006).  
 The mechanism of the repression by NPAS1 is not investigated thoroughly. 
The cofactors involved in the formation of an active complex which represses TH, 
however is not known. Only a bHLH motif, two PAS domains and a PAS associated 
C-terminal motif have been identified in the NPAS1 molecule. In the AhR, for the 
minimal ligand binding domain is already identified. The ligand or environmental cue 
for NPAS1 has not been identified although the target genes for which NPAS1 
represses are known. 
NPAS1 associated with GABAergic interneurons 
 Although, our group has shown an association of NPAS1 with dopaminergic 
neurons (through MN9D subtractive hybridisation), there is no literature showing that 
NPAS1 is associated with dopaminergic neurons in animal models. It is however, 
shown to colocalize mainly with gamma aminobutyric acid (GABA) and glutamic 
acid decarboxylase 67 (GAD67) and calretinin (Erbel-Sieler et al., 2004). Thus it was 
proposed that NPAS1 is primarily expressed in GABAergic inhibitory interneurons 
(Erbel-Sieler et al., 2004). However not all NPAS1 expressing neurons are seen to 
colocalize with GABA, GAD67 and calretinin. Furthermore, in the human striatum, it 
has been shown by double in situ hybridisation with radioactive probes that 31% of 
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calretinin expressing neurons also express TH, and 100% of the cells that express 
GAD65 (an isoform of GAD) also express TH (Cossette et al., 2005). Therefore, the 
work by Erber-Sieler et al. (2004) does not exclude the possibility that NPAS1 is 
coexpressed with TH.  
 Another clue is offered by another bHLH-PAS protein, EPAS1. EPAS1 was 
found to colocalize with TH and it is also expressed in non-vascular sites like the liver 
and kidney (Favier et al., 1999). EPAS1 is another hypoxia inducible factor and 
therefore its expression might be related to NPAS1 since it was observed that NPAS1 
represses two hypoxia regulated genes (EPO and TH).  
NPAS1 might be involved in the late development of the brain 
 It was shown that hypoxia results in accumulation of HIF-1α and EPAS1 in a 
variety of human neuroblastoma cells (Jögi et al., 2002). At the same time, TH and 
vascular endothelial growth factor (VEGF) are also shown to be upregulated as 
revealed by Western blot and northern blot respectively. What is even more 
interesting is that the neuroblastoma cells appear to dedifferentiate and acquire a 
neural crest phenotype (Jögi et al., 2002). This conclusion was reached when they 
observed the increase in expression of neural crest genes like Id2 and Notch-1 and 
HES-1 when neuroblastoma cells were exposed to hypoxia. This implicates an in vivo 
event when hypoxia induced genes (like EPO and TH) might be repressed in normal 
development of the brain. Given the late expression of NPAS1, this event might take 
place in the later stages of brain development.  
NPAS1 and NPAS3: factors possibly related to schizophrenia 
 NPAS3 shares 50.2% amino acid identity (Brunskill et al., 1999) with NPAS1. 
Erber-Sieler et al. (2004) used targeted gene disruption to investigate the effects of 
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mice deficient in NPAS1 and NPAS3 and NPAS1/NPAS3 double deficient mice. 
They had primarily focused their efforts to link the two genes with schizophrenia as it 
was reported that a disruption in the NPAS3 locus was discovered in a family with 
history of schizophrenia (Kamnasaran et al., 2003). In the larger isoform of the 
disrupted NPAS3, the bHLH, PAC and the nuclear localisation motif in the C-
terminus remains intact but the PAS domains, which are important for dimerization 
are disrupted. 
  NPAS3 deficient and NPAS1/NPAS3 double deficient mice were shown to 
behave abnormally for a range of behavioural tests like startle response, social 
recognition. In addition, they had stereotypic darting behaviour and enhanced 
locomotor activity (Erbel-Sieler et al., 2004).  NPAS1 deficient mice had no 
observable difference in body weight. A slightly smaller than normal and irregular 
step size was observed in NPAS3 deficient and NPAS1/NPAS3 double deficient mice 
giving them an abnormal gait. NPAS3 deficient and NPAS1/NPAS3 double deficient 
mice had a 20% reduction in body weight compared to the wild type. This trend of 
abnormality was extended to tests where they examined reaction to tail suspension, 
postural reflex to cage shake, and intruder response (using a q-tip). There was no 
observable difference between NPAS3 deficient and NPAS1/NPAS3 double deficient 
mice in these tests. Whilst NPAS1 deficient mice had no observable difference with 
wild type mice in the tests mentioned above. Of the 89 mice examined 4 of them 
exhibited a stereotypic darting behaviour not seen in the rest of the mice. The mouse 
is seen to occasionally dash forward without regard to its surroundings, sometimes 
bumping into the cage or its cage mates. These four mice were all “homozygous null 
at NPAS3 locus and either homozygous null or heterozygous at the NPAS1 locus.” 
The defining difference between these four mice and the rest of the 85 mice is the 
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disruption of the NPAS3 gene. Hence it was supposed that NPAS3 is responsible for 
this darting behaviour.  
 There is a difference between maternal care instinct in females belonging to 
NPAS3 deficient and NPAS1/NPAS3 double deficient mice versus normal behaviour 
observed in wild type mice. The mother mice which were deficient in NPAS3 or 
NPAS1/NPAS3 did not display typical nesting behaviour. Nesting material that was 
provided, was not used. Although pup retrieval tests were not done, from the video 
footage provided it seemed that the abnormal mother did not seem to gather its pups 
together. This lack of certain aspects of maternal behaviour resulted in pup mortality 
two days postpartum (Erbel-Sieler et al., 2004). 
 It was probably expected by Erber-Sieler et al. (2004) that the NPAS3 
deficient mice show an attenuated abnormal behaviour with regards to 
NPAS1/NPAS3 double deficient mice. The reason being that since NPAS1 deficient 
mice showed no abnormal behaviour, and given that NPAS1 and NPAS3 share a 
50.2% similarity, it is possible that NPAS1 duplicates the function of NPAS3. 
However, in quantitative behavioural assays, where the attenuation can be observed, 
the data to show that NPAS3 deficient mice have an intermediate phenotype between 
wild type and double deficient mice was not of statistical significance.  
 Analysis of the neurons where NPAS1 function is removed showed that the 
inhibitory interneurons are present and the distribution of these interneurons is 
indistinguishable from wild type. For NPAS3, indirect evidence through the staining 
of GAD67, showed the same trend as NPAS1. Furthermore, as the GAD67 
distribution and staining looked similar to wild type for NPAS3 mice, it suggests that 
the raison d'être for the abnormal behaviour is not the disruption of the key machinery 
to produce GABA. Other than GAD67, parvalbumin, neuropeptide Y, calbindin D-
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28k, calretinin, reelin and GABA were tested for change in expression between the 
NPAS1, NPAS3 and NPAS1/NPAS3 double deficient mice compared with wild type 
mice. Only reelin showed a reduction in antibody staining in mice brain sections for 
all 3 mice when compared with wild type. Reelin is thought to play an important role 
in ensuring that migrating neurons reach their proper location and orientation 
(Tissirand and Goffinet, 2003).  
3 dimensional structure of dPER 
 The most complete 3D structure that is solved for a PAS domain protein is that 
done of a fragment (232 to 599) of Drosophila PERIOD (dPER) (Yildiz et al., 2005). 
This fragment covers the PAS A and PAS B domains (238-512) and part of the C-
terminus (the entire protein is 1224 amino acids) (Yildiz et al., 2005). The dPER 
structure solved showed a noncrystallographic homodimer with PAS A of molecule 1 
binding PAS B of molecule 2 and vice versa (see Figure 1). The PAS domain is made 
of 5 anti-parallel beta-sheets (designated beta-A to beta-E) flanked by 4 alpha-helices 
(alpha-A to alpha-D). This structure is mirrored in both PAS A and PAS B. The C-
terminal sequence forms two alpha-helices (alpha-E and alpha-F). Alpha-E runs 
parallel to alpha-C of the PAS B domain to cover the PAS B domain. Alpha-F is an 
interesting feature of the dPER homodimer structure. Alpha-F takes two different 
conformations in for each molecule in the dPER homodimer. Alpha-F from molecule 
2 has a sharp kink which allows it to be associated with the beta-sheet of PAS A 
domain of molecule 1. Alpha-F from molecule is extended out and covers the beta-
sheet of the PAS A domain as well, but it is of another molecule (not from the 
homodimer unit examined), which forms an oligomer along the 4-fold 
crystallographic axis (Yildiz et al., 2005). The alpha-F and PAS A association 
includes hydrophobic interactions and a salt bridge (between Glu566 of alpha-F and 
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Arg345 of PAS A) which are identical for both molecules. The only difference in the 
alpha-F and PAS A association is a result of the kink in the alpha-F of molecule 2, 
which has the sidechain for Tyr253 twisted for stabilization.  
 
Figure 1. 3D model of dPER homodimer.  
The 1st molecule (Chain A) is colored yellow, and the 2nd molecule (Chain B) is 
colored blue. To highlight the C-terminal alpha helix (alpha-F), the helix is colored 
red for both molecules. The alpha-F of the 2nd molecule is seen to have a kink and 
associate with the PAS A of the 1st molecule. The alpha-F of the 1st molecule points 
away as in the crystal, it associates with the PAS A domain of another dPER 
molecule. 
 
The 3D structure hinted at the importance of alpha-F in the homodimerization 
of dPER. Gel filtration of dPER and dPER with the alpha-F deleted showed that 
dPER elutes out before dPER with alpha-F deleted. Furthermore, by comparison with 
other markers, dPER does behave as a homodimer, whereas, the latter is eluted out as 
a monomer. Oligomers (more than a pairing of two) of dPER were not found in the 
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gel filtration experiment. Oligomers were present in the crystal and formed as a result 
of the alpha-F taking a conformation state without a kink to associate with the PAS A 
of the third molecule. Two other studies support the PAS A and alpha-F association. 
Yeast two hybrid assays (Huang et al., 1995) have verified this interaction in two 
dPER fragments: a PAS A containing fragment (amino acids 232-290) and an alpha-F 
containing fragment (amino acids 524-685). Furthermore, a mutation in the PAS A 
beta sheet (Val243 to Asp) leads to the mutated dPER eluting as a monomer in the gel 
filtration experiment (Yildiz et al., 2005). In the 3D structure of dPER, Val243 has its 
side chain packed closely to Met560 and Met564 of alpha-F. Physiologically, the 
same mutation leads to a temperature-dependent 29 hour long-period phenotype 
(Konopka and Benzer, 1971). The phenotype might be a result of the disruption of 
PAS A and alpha-F association.    
 Given the functional significance of the alpha-F for dimerization, it would be 
interesting to find that this region is well-conserved across all bHLH-PAS proteins, 
thus providing a paradigm for bHLH-PAS proteins' dimerization. Unfortunately, this 
is not the case as evidenced by multiple sequence alignment done with CLUSTALW 
by the author and others (Yildiz et al., 2005) of several bHLH-PAS proteins. 
Sequence alignment showed non-conservation of the sequence responsible for alpha-F 
across a range of bHLH-PAS proteins except for PERIOD proteins from arthropods. 
A plausible explanation offered by the author is that the PAS A and alpha-F 
association might occur in vivo but variations in the contact regions might account for 
dimer partner specificity. For example, ARNT forms homodimers (Levine and 
Perdew, 2002) as well as heterodimers with bHLH-PAS proteins like AhR, HIF-1α, 
SIM1 and EPAS1 (Alfarano et al., 2005). Accordingly, the PAS A and alpha-F 
association has to accommodate this flexibility in selecting for these dimer partners. It 
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is not found to bind dPER thus it is not unreasonable to expect a variation in sequence 
in the alpha-F for ARNT. 
Objectives of this study 
 NPAS1 is just beginning to be characterized, as papers describing the function 
of NPAS1 are not numerous. There are gaps in our knowledge about the NPAS1 
molecule. For example, an association between NPAS1 and dopaminergic neurons 
has not been established in the animal model. In addition, the regions of the NPAS1 
molecule responsible for its repression activity are not known.  
 This study aims to address the gaps in the knowledge about NPAS1. 
Immunofluorescence staining for NPAS1 using mice as an animal model was done to 
verify the colocalization of TH and NPAS1. Other than establishing that NPAS1 is 
expressed in dopaminergic systems, the staining will also hopefully show the spatial 
and temporal aspects of NPAS1 in embryonic mice. Although the bHLH, PAS and 
PAC motifs have been described in the NPAS1 molecule, other parts of the molecule 
is not well studied. This study attempts to further demarcate the regions of repression 
in NPAS1 building upon earlier studies that have shown repression activity in both 
the N-terminus and the C-terminus. Deletion clones are fused to two different 
constructs to test for repression in yeast and mammalian cells. Using the 3D structure 
of dPER, the implications of the regions of repression are examined.  
 EPO and TH are known to be upregulated by HIF-1α. In addition, NPAS1 
appears to be able to repress genes driven by HRE in luciferase experiments. This 
suggests an antagonistic role of NPAS1 versus HIF-1α. The implication is that co-
activators of HIF-1α regulated genes might interact with NPAS1 as well. Hence, 
experiments to address these issues were attempted here. The interactors of NPAS1 
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are also examined with the purpose of trying to identify other members which form 
the active repression complex with NPAS1. 
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2. Materials & method 
NPAS1 immunofluorescence staining 
 Swiss Webster outbred albino mice were kept in a constant environment at 
Animal Holding Unit, AHU (National University of Singapore, NUS). Sexually 
mature mice were mated after one week of acclimatisation. Female mice observed to 
have a vagina plug the day after mating were separated and deemed to be pregnant 
with embryonic day 0.5 (E0.5). The pregnant mice were euthanized according to 
guidelines provided by AHU. The embryos were dissected in cold PBS and fixed in 
2% paraformaldehyde in PBS for 2 hours at 4 °C. The embryos were transferred to a 
25% sucrose solution in PBS overnight at 4 °C. The embryos were then set in agar 
blocks (1% agar, 25% sucrose in PBS) or immersed in embedding material (OCT 
Tissue Tek compound, Miles Scientific). The tissues were chilled to -20 °C and 
sectioned using a cryostat (Leica). The 30 µm saggital sections were thaw mounted on 
to slides. 
 The sections were blocked with diluted goat serum (Vector Laboratories, 
USA) for 30 min. Primary antibody incubation for TH staining was done with anti-TH 
(Immunostar monoclonal, USA) with a ratio of 1:500 in PBS for 3 hours. The slides 
were washed with 0.2% Triton X-100 in PBS for 3 x 10 min. For secondary antibody 
incubation, 1:500 dilution was used for Cy2 anti-mouse IgG in PBS for 1.5 hours. The 
slides were washed with 0.2% Triton X-100 in PBS for 3x 10 min. Primary antibody 
incubation for NPAS1 was done overnight with rabbit anti-NPAS1 (a kind gift from 
Dr Masayuki Miura from University of Tokyo, Japan) at a ratio of 1:100. The slides 
were washed with 0.2% Triton X-100 in PBS for 3x 10 min. Secondary antibody 
incubation was done with rhodamine-coupled goat anti-rabbit IgG (Santa Cruz 
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Technologies, USA) for 4 hours. The slides were then washed with 0.2% Triton X-
100 in PBS for 3x 10 min. 
Preparation of competent bacteria cells 
For the preparation of competent bacteria cells, 1 ml of an overnight culture of 
Escherichia coli (E. coli) strain BL21 was innoculated into 200 ml of fresh LB 
medium. The flask was placed in an incubation oven and regular readings of OD600 
were taken. When the readings reached approximately 0.5, the culture was chilled on 
ice for 15 min and transferred to pre-chilled sterile 50 ml Falcon tubes. Cells were 
gently pelleted by centrifugation at 1500x g at 4 °C for 10 min. The cell pellets were 
re-suspended in total of 60 ml of pre-chilled MgCl2/CaCl2 solution (80 mM MgCl2, 20 
mM CaCl2). After incubation on ice for 10 min, the cells were recovered by 
centrifugation at 1500x g at 4 °C for 10 min. The cell pellets were resuspended in 2 
ml of pre-chilled 0.1 M CaCl2 for each 50 ml of original bacteria culture. 4 ml of 
freezing medium (50% glycerol (v/v), 50% (v/v) 0.1M CaCl2) was added to 2 ml of 
the resuspended pellet 100 µl and 200 µl aliquots were dispensed in microcentrifuge 
tubes and stored at -80 °C.  
In vitro interaction studies 
Bacterial transformation 
 Competent cells were thawed on ice after which 5 µl of the ligation mix was 
mixed with the competent cells and incubated on ice for 20 min. The cells were then 
heat shocked at either 42 °C for 45 sec or 37 °C for 5 min. Following heat shock the 
cells were kept on ice for 2 min before adding 400 µl of LB (Invitrogen, USA) and 
incubated with shaking for 45 min at 37 °C for the cells to recover. The cells were 
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then plated on LB agar medium with the appropriate antibiotics (50 µg/ml for 
ampicillin and 30 µg/ml for kanamycin). 
Cloning of the expression plasmids for in vitro interaction 
 For the initial experiments fl NPAS1 was cloned into pGEX4T1 into the SmaI 
XhoI sites of the MCS, multiple cloning sites. pcDNA3.1 (+) plasmid containing full-
length ARNT was a kind gift from Dr. Jacques Michaud (Research Center, Hospital 
Sainte-Justine, Montreal, Canada). The forward primer 5’ TAC GCA GGA TCC ATG 
GCG GCG ACT ACA GCT 3’ with a BamHI cut site and the reverse primer 5’ GGT 
CGA GTC GAC CTA TTC GGA AAA GGG GGG 3’ with a SalI cut site was used to 
amplify the ARNT. The amplicon was digested and the full-length gene was cloned 
into the BamHI and SalI sites of pMAL C2X for in vitro interaction studies. Full-
length NPAS1 was amplified from pcDNA3.1(-) fl NPAS1 GFP using this forward 
primer with HindIII RE site 5' GGA TCC AAG CTT CGA TGG CGA CCC CCT 
ATC CC 3'  and the reverse primer with XhoI RE site 5' GTC GAC CTC GAG TCA 
GTC TCC CTT CCG CTG CAC CCT 3' the amplified NPAS1 was gel purified 
(Qiagen, Qiaquick Gel Extraction kit, USA) and cut with  HindIII  XhoI RE and 
cleaned up with Qiagen PCR purification kit (Qiagen, USA). The purified NPAS1 
was then ligated into pET24D GST TEV (a kind gift from Dr Simos from University 
of Thessaly, Greece) using the HindIII XhoI sites.  
Pull down of MBP tagged proteins 
 Cell suspensions were sonicated by 6 second bursts with a rest of 3 seconds 
for 2 min and 40% amplitude with Sonics Vibracell VC130 (Sonics, USA). 
Subsequently, lysates were cleared by centrifugation for 30 min at 13,000x g at 4 °C. 
For the pull down of MBP tagged proteins with the amylose resin, 40 µl of 50% slurry 
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of amylose resin (New England Biolabs, UK) was added to each cell lysate and 
incubated at 4 °C with rotation for 3 h. Unspecific binding was removed by 5 washes 
with 2% Triton X-100 in PBS. Elution of the bound proteins was done with 20 µl of 
elution buffer (1% Triton X-100, 10 mM DTT, 10 mM maltose supplemented with 
protease inhibitor (Roche Complete Protease Inhibitor Cocktail, USA) in PBS). The 
beads were spun briefly to retrieve the eluates. The fourth eluate was used to run a 
SDS-PAGE and the proteins were transferred to a nitrocellulose membrane. 
Pull down of GST tagged proteins 
 Western blot for GST was done after the membrane was incubated overnight 
at 4 °C with primary mouse anti-GST (Santa Cruz, USA) at a dilution of 1:1000. For 
the Western blot for MBP, HRP conjugated mouse monoclonal antibodies were used 
at a dilution of 1:500 for an overnight incubation at 4 °C.  
 For the verification of expression of fusion proteins in the beta-galactosidase 
and luciferase experiments, the primary antibodies for GAL4 (Santa Cruz 
Technologies, USA) and LexA (Santa Cruz Technologies, USA) were also used at 
1:1000 dilution for an overnight incubation at 4 °C. 
 For the pull down of GST tagged proteins, 40 µl of a 50% slurry of 
Glutathione Sepharose™ 4B resin beads (Amersham Biosciences, Sweden) was 
incubated with the cell lysate overnight with rotation at 4 °C. Unspecific binding was 
removed by 5 washes with 2% Triton X-100 in PBS. Further washing was done with a 
buffer containing 10 mM reduced glutathione (Amersham Biosciences) in PBS 
supplemented with protease inhibitor (Roche Complete Protease Inhibitor Cocktail, 
USA). The beads were spun briefly to retrieve the supernatant for analysis. Washing 
with the buffer containing reduced glutathione was repeated 3 times. Western blots of 
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the supernatant showed only MBP tags being eluted (not shown). Only the Western 
blot for the SDS-PAGE of the beads was shown in Figure 10. 
Western blot analysis 
 Proteins were separated by 12% SDS-PAGE and transferred onto a 
nitrocellulose membrane (Bio-Rad Laboratories, USA). A wet transfer method was 
used while the transfer unit was placed on ice to keep it cool. Pre-chilled transfer 
buffer (190 mM glycine, 25 mM Tris-HCl, pH 7.4 & 20% methanol) was used as 
well. Membranes were blocked in blocking buffer (5% non-fat dry milk, 10 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 20) for 45 min. Primary antibody 
incubation was done overnight at 4 °C with the antibodies diluted in blocking buffer 
with 2% non-fat dry milk. Membranes were washed of unspecific binding with TBST 
buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 20) for 5 times, each 
with 5 min duration.  Secondary antibody incubation took 2 hr with the antibodies 
diluted in blocking buffer with 2% non-fat dry milk. Membranes were probed with the 
respective primary antibodies and the corresponding HRP-conjugated secondary 
antibodies (Santa Cruz Technologies, USA) anti-rabbit IgG HRP (1:1000 dilution, 
Santa Cruz Technologies, USA) or anti-mouse IgG HRP (1:1000 dilution, Santa Cruz 
Technologies, USA). Proteins were visualized with Pierce ECL Western Blotting 
Substrate (Pierce Biotechnology Inc, USA) and CL-XPosure Film (Pierce 




Cloning of the NPAS1 fragments for the beta-galactosidase experiment in 
yeast 
The pcDNA3.1(+) fl ARNT plasmid was used as a template with the 
following primers 5’-TGG CTG GAA TTC GCA GAG AAT TCC AGG AAT -3’ and 
5’-TCG ACG GAT CCC TTC GGA AAA GGG GGG AAA CA-3’. The amplified 
DNA product was digested with restriction enzymes EcoRI and BamHI and ligated 
into pLexA vector. 
Plasmids for the beta-galactosidase experiment in yeast were constructed 
using pLexA ARNT C as the parent plasmid. pLexA ARNT C is an expression 
plasmid encoding a LexA DBD epitope-tagged version of ARNT C-terminus without 
the stop codon. The NPAS1 fragments were first PCR amplified from pcDNA3.1 (-) 
fl NPAS1 GFP (template). The primer pairs used for each fragment are listed in Table 
1.  
PCR amplification was done with Pfu polymerase (Strategene, USA) on PTC-
100TM programmable thermal controller (MJ Research, USA). The conditions for the 
PCR were 95 °C for 2 min and 34 cycles of 95 °C for 30 s, 55 °C for 30 s, 72 °C for 2 
min (may vary according to length of expected amplicon) followed by a final 
extension step at 72 °C for 7 min.  
The amplified DNA product was digested with the restriction enzymes NcoI 
and XhoI (Promega, USA) and subsequently ligated into pLexA ARNT C vector 
using T4 DNA ligase (Promega, USA). 
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Table 1. Sequence of primers used to clone the NPAS1 fragments.  
The primers are arranged in primer pairs on the left. The first primer (which is in the 
forward direction) has an NcoI site whilst the second primer, which is in the reverse 




Amino acid numbering 

































Preparation of the liquid culture for yeast 
 Liquid media for the plates were prepared according to manufacturer's 
recommendations (Qbiogene, Bio 101 Systems Yeast media, USA). Synthetic dropout 
media (SD) that were lacking in Ura (-Ura) was used to maintain p8opLacZ in the 
EGY48 yeast cells.  SD media that were lacking in Ura and His (-Ura/-His) were used 
for the growth of transformed colonies for quantitative beta-galactosidase assay.  After 
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autoclaving at 121 °C for 20 min, BU salts (1x solution contains 25 mM sodium 
phosphate buffer pH 7.0), was added to the media.  
Preparation of the agar plates for yeast 
 Media for the plates were prepared according to manufacturer's recommendations. 
2% (w/v) agar was added to synthetic dropout media (SD) that were lacking in Ura 
and His (-Ura/-His) were used for the selection of transformed colonies. After 
autoclaving at 121 °C for 20 min, BU salts (1x solution contains 25 mM sodium 
phosphate buffer pH 7.0), X-gal (80 mg/L) was added to the media before pouring 
into plates. The media contained 2% galactose and 1% raffinose which increased the 
specificity of the repression assay.  
Yeast transformation 
 EGY48 yeast cells that were pretransformed with p8opLacZ were maintained 
on SD/-Ura plates to keep the selection for the p8opLacZ. Before transformation the 
EGY48 cells were grown in liquid culture SD/-Ura overnight at 30 °C. 1 ml of 
overnight culture of EGY48 in SD/-Ura was harvested by centrifugation for 1 min at 
5000x g. The supernatant was discarded and the pellet was resuspended in 95 µl of 
one step transformation buffer (200 mM LiCl, 40% (v/v) PEG-3550, 100 mM DTT). 
The suspension is transferred into a microcentrifuge tube containing premixed 300 ng 
of plasmid DNA and 50 µg of Herring sperm DNA. The mixture is vortexed and 
incubated 45 °C for 30 min. Thereafter, the yeast suspension was plated out on SD/ -
Ura -His plates and placed in an incubation oven set at 30 °C. DNA concentration was 
measured using NanoDrop (NanoDrop Technologies, USA). 
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Qualitative X-gal assay 
 Transformed colonies were transferred to yeast agar plates containing 
selection dropout media (lacking in Ura and His), BU salts, and X-gal. Plates were 
incubated at 30 °C for up to 4 days. Plates were checked every 24 hours for colour 
change.  
Quantitative X-gal assay 
 Transformed colonies were grown in 1 ml of yeast liquid media overnight at 
30 ºC. The yeast beta-galactosidase assay kit (Pierce Biotechnology, USA) was used 
to determine the beta-galactosidase activity. The stopped microplate assay protocol 
listed in the manufacturer’s instructions was used. The OD660 of the yeast cultures for 
the different clones were measured in a microplate and noted. 70 µl of the working 
solution (WS) was added to 70 µl of yeast culture in each well. The timer was started 
to record the reaction time for the well contents to turn yellow. The timer was stopped 
when the first well turned yellow and 56 µl of the stop solution was added to each 
well and mixed gently. A well containing only the 70 µl of yeast culture media (with 
the WS and stop solution added) was used as a blank at OD420. Calculations were as 
per manufacturer’s instructions.  
Dual luciferase assay in mammalian cells 
Cell culture of HEK293 and MN9D cells 
 All of the media used for mammalian cell culture were prepared according to 
manufacturer's recommendations and added with 10% v/v fetal bovine serum 
(Hyclone, USA) and 1% v/v penicillin-streptomycin (Gibco BRL, USA). Both cell 
lines were maintained at 37 ºC in a humidified atmosphere of 5% CO2 incubators 
(Sanyo, Japan). HEK293 cells were grown in DMEM media. The murine clonal 
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MN9D cells were from Dr Jun Chen of University of Pittsburgh and were used with 
permission from Dr Alfred Heller of University of Chicago. MN9D cells were grown 
in DMEM media. For transient expression of proteins, cells were grown to 70% 
confluency and transfected with Lipofectamine 2000 (Invitrogen, USA) as 
recommended by the manufacturer.  
 
Plasmids used for the Dual Luciferase Assay 
 For the luciferase assay for repression activity, the cells were co-transfected 
with the 1.25 ng of pRL-SV40 Vector as internal control reporter, 160 ng of the 
pGAL4 TK Luc reporter plasmid (a kind gift from Dr Ng Huck Hui of NUS), and 640 
ng of the test plasmid which is the parent vector of pM and the truncation construct of 
murine NPAS1.  The pGAL4 TK Luc reporter plasmid contains 4 tandem GAL4 
binding sites and a thymidine kinase promoter driving the expression of firefly 
luciferase. The pRL-SV40 vector contains a cDNA (Rluc) encoding Renilla 
luciferase, which was originally cloned from the marine organism Renilla reniformis 
(sea pansy). The SV40 early enhancer/promoter region provides strong, constitutive 
expression of Rluc. Both the firefly luciferase and Renilla luciferase do not require 
post-translational modification for activity. Thus the enzymes may function as 
reporters immediately following translation. Dual Luciferase Assay was carried out 
using the Promega Dual-Luciferase® Reporter Assay System (Promega, USA). 48 
hours after transfection, cells grown in 24-wells plates were washed twice with cold 
PBS and lysed in 100 µl of 1 X Passive Lysis Buffer (provided). The cell lysate was 
collected and to clarify the cell debris, it was then centrifuged at 15000x g at 4 ºC for 
5 min. 100 µl of LAR II (provided) was added to a clean borosilicate glass tube 
followed by 20 µl of cell lysate and mixed vigorously. Luminometer readings 
(measured in relative luminescence units, RLU) was taken and recorded in 5 seconds 
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intervals. Readings (for firefly luciferase activity) were recorded till two or more 
readings showed a decrease. Subsequently, 100 µl of Stop & Glo Reagent (provided) 
was added and mixed vigorously. Luminometer readings for Renilla luciferase 
activity was taken and recorded in 5 seconds intervals. Similarly, readings for Renilla 
luciferase activity were taken till two or more readings showed a decrease. The values 
were digitised and analysed. 
 The highest reading for each tube was taken to be the maximum. Firefly 
luciferase activity was normalised to the Renilla luciferase by dividing the former 
over the latter. The resulting values were examined in terms of fold differences 
between the control cell lysate of the cells transfected with pM. Student's T test was 
performed to check for statistical significance. 
Cloning of the NPAS1 fragments for the mammalian hybrid work 
For mammalian hybrid work, expression plasmids for the NPAS1 fragments 
were constructed by first digesting the pLexA ARNT C-terminus NPAS1 (fragment) 
with SalI (Promega, USA). After which, the NPAS1 fragment was gel purified with 
QIAquick Gel Extraction Kit (Qiagen, USA) and ligated to pM vector with T4 DNA 
ligase (Promega, USA). Bidirectional PCR sequencing was conducted using ABI 
3100 Genetic Analyzer Automated Capillary DNA Sequencer (Applied Biosystems, 
USA) using Big Dye Terminator V3.1 (Applied Biosystems, USA) to verify the 




In vivo pull down with FLAG tagged NPAS1 
Cloning of the NPAS1 into FLAG tag for in vivo interactors 
 Full-length NPAS1, NPAS1 N-terminus and C-terminus were cloned into 
pXJ40 FLAG plasmid previously (Teh, 2006). 
Cell harvest and Immunoprecipitation 
 HEK293 cells were grown in 10 cm cell culture plates and were transfected 
with 12 µg of 4 different plasmids at 80% confluency. The 4 plasmids are pXJ40-
FLAG, pXJ40-FLAG fl NPAS1, pXJ40-FLAG NPAS1 N-terminus, and pXJ40-
FLAG NPAS1 C-terminus. 48 hours after transfection, the cells were harvested. Cells 
were washed twice with cold PBS solution before adding 1 ml of cell lysis buffer (100 
mM HEPES pH 7.5, 5 mM MgCl2, 150 mM NaCl, 1 mM EDTA and 1% Triton X-
100) supplemented with a protease inhibitor cocktail (Roche Complete Protease 
Inhibitor Cocktail, USA), and 1 mM dithiothreitol (DTT). The cells were scraped 
down with a cell scraper. 
 For the silver stained gel, 4 plates of transfected cells of each plasmid were 
used to make up 1 ml of cell lysate with the cell lysis buffer. Anti-FLAG® M2 
agarose beads (Sigma, Germany) were added to a microcentrifuge tube containing 1 
ml of cell lysate. The tubes were incubated with the beads overnight on a rotator and 
kept at 4 ºC throughout the duration. The beads were washed of unspecific binding 
with 1% Triton X-100 in PBS for 5 times. The beads were spun down gently at 1000 
rpm using refrigeration when possible. After the washings, the protein was loaded into 
a gel which was subsequently stained with silver.  
 For the Coomassie stained gel, 3 plates of transfected cells of each plasmid 
(full-length, N-terminus and C-terminus) and one plate of empty pXJ40-FLAG, were 
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used to make up 1 ml of cell lysate with the cell lysis buffer. Anti-FLAG® M2 
agarose beads (Sigma, Germany) were added to a microcentrifuge tube containing 1 
ml of cell lysate. The tubes were incubated with the beads overnight on a rotator and 
kept at 4 ºC throughout the duration. The beads were washed of unspecific binding 
with 1% Triton X-100 in PBS for 10 times. The beads were spun down gently at 1000 
rpm using refrigeration when possible. After the washings, the protein was loaded into 
a gel which was subsequently stained with silver.  
Silver staining 
 The reagents for silver staining were prepared fresh whenever possible. As the 
protocol is very sensitive, apparatus used for silver staining were also kept clean to 
the highest possible standard. The gel was fixed in 40% methanol / 10% acetic acid 
for 30 min, followed by 50% methanol for 15 min. The gel was washed five times 
with Milli-Q water for 5 min. The gel was then sensitized with 0.02% (w/v) of sodium 
thiosulfate for 1 min. After two washes with Milli-Q water for 1 min, pre-chilled 
0.2% (w/v) silver nitrate solution was added. The gel was incubated for 25 min in the 
dark. The silver solution was removed and the gel was washed twice with Milli-Q 
water for 1 min. The gel was then developed using a solution of 3% (w/v) of sodium 
carbonate (anhydrous) and 0.001% (v/v) of formaldehyde for 5 min. The previous 
solution was removed and fresh developing solution was added and the gel was 
further incubated till the desired level of staining was achieved. Subsequently, the gel 
was washed twice with Milli-Q water for 1 min and 5% (v/v) acetic acid was added to 
stop the reaction. The gel was stored in 1% acetic acid until the gel was scanned and 
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Coomassie stain 
 The gels were stained with Coomassie staining solution (40% (v/v) methanol, 
7.5% (v/v) acetic acid, 52.5% Milli-Q water and 0.2% (w/v) Coomassie Brilliant Blue 
R250) with gentle rocking overnight. Destaining was done with destaining solution 
(40% (v/v) methanol, 10% (v/v) acetic acid and 50% Milli-Q water) with a piece of 
kimwipe added to soak up the stain. The destaining solution was changed with a fresh 
solution until the background stain was reduced to an acceptable level.  
Gel scans 
 Both the gels were scanned using Biorad GS-800 calibrated densitometer. 
Using FLAG beads as a negative control, and FLAG tagged full-length NPAS1, bands 
that represent in vivo binding to full-length, N-terminus and/or C-terminus were cut 
out. The bands are then reduced with DTT and alkylated with iodoacetamide before 
being digested with trypsin. The detailed steps are described below. 
In-gel reduction, alkylation and trypsin digestion 
 The solutions for the in-gel reduction, alkylation and trypsin digestion were 
prepared fresh whenever possible. Sequencing grade trypsin was used to make up the 
digestion solution. The solutions were also made with Milli-Q water (Millipore, 
USA). The solution containing iodoacetamide was stored in darkness after being 
prepared. 
 After using a clean scalpel to isolate the band being immunoprecipitated, the 
gel band was further cut into smaller pieces and transferred to a microcentrifuge tube. 
The gel pieces were then immersed in a solution of 50 mM ammonium bicarbonate 
(NH4HCO3) / 50% (v/v) acetonitrile (HPLC grade). The tube was vortexed and 
allowed to stand for 5 minutes before discarding the solution. This wash/dehydration 
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step was repeated thrice. The gel pieces were further dehydrated with approximately 
50 µl acetonitrile. The tube was again vortexed and allowed to stand for 5 minutes. 
The solvent was carefully removed using a fine gel-loading pipette tip. This 




 The samples required reduction as the band was cut from a 1D SDS-PAGE. 
The gel was soaked in a freshly prepared solution of 10 mM DTT (BioRad, USA) in 
100 mM ammonium bicarbonate. To remove oxygen, the tube was flushed with 
nitrogen gas. The tube was then capped tightly and incubated at 57 ºC for 60 min. 
Alkylation 
 The samples were next alkylated. The tubes were allowed to cool to room 
temperature before the DTT solution was removed. Subsequently, a 55 mM 
iodoacetamide (Sigma-Aldrich, USA), 100 mM ammonium bicarbonate solution was 
added. Once again, to remove oxygen, the tube was carefully flushed with nitrogen 
gas. The tube was subsequently capped, wrapped in aluminium foil and kept at room 
temperature for 60 min, vortexing every 15 min. 
Washing 
 Using a gel-loading pipette tip, the solution was removed carefully. Samples 
were then treated with 100 µl of 100 mM ammonium bicarbonate solution and mixed 
by vortexing. The washings were carefully removed by pipetting after allowing 
solution to stand for 5 minutes at room temperature. 
Gel Dehydration 
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 The gel was dehydrated again by treating with approximately 100 µl 
acetonitrile, then vortexed and allowed to stand for 5 minutes. After which, the 
supernatant was carefully pipetted out.  
Re-swelling 
 Re-swelling of the gel particles were carried out by adding 100 µl of 100 mM 
ammonium bicarbonate, mixed and left to stand for 5 minutes. Removal of the 
supernatant was done carefully by pipetting. 
Second Dehydration 
 The gel dehydration step was repeated as described above. It was then dried to 
completion in a speedvac. 
Re-swelling 
 15-30 µl of digestion solution (12.5 ng/µl trypsin in 50 mM ammonium 
bicarbonate solution) was added and allowed to enter the dehydrated gel. This 
incubation step took place at 4 ºC for 30 minutes. 
Digestion 
 Excess trypsin solution was removed and 15 µl of 50 mM ammonium 
bicarbonate solution was added. The gel pieces were left for incubation overnight (6-
15 hours) in an oven or a thermocycler set at 37 ºC. 
Extraction Step 
 During extraction, the gel particles were first cooled to room temperature, and 
then it was centrifuged for 10 minutes at 6000 rpm in a microcentrifuge. The 
supernatant was collected by careful pipetting. 20 mM ammonium bicarbonate was 
added to the gel, then spin down and its supernatant collected as above. A third 
treatment using 10-25 µl of 5% formic acid in 50% aqueous acetonitrile was then 
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carried out. It was left to stand for 5 to 10 minutes and then centrifuged at 6000 rpm 
for 10 min. The supernatant was again pipetted out carefully and collected.  
 All 3 supernatants from the extraction step were combined and dried in a 
vacuum centrifuge. 
Sample preparation and instrument setting for MS and MS/MS analysis 
 The sample preparation and instrument handling was undertaken by the staff 
at the Protein and Proteomics Centre (PPC, National University Singapore). The 
procedure is quoted here. The extracted peptides were dissolved in a solution that 
contained 0.1% (v/v) Trifluoroacetic Acid (TFA) and 50% (v/v) Acetonitrile (ACN). 
Subsequently, 0.5 µl of extracted peptides were spotted on a 96X2 well target plate 
and crystallized with 0.5µl of CHCA matrix solution (5 mg/mL). The matrix solution 
was a saturated solution consisted of α–cyano-4-hydroxycinnamic acid (CHCA) in 
0.1% (v/v) Trifluoroacetic Acid (TFA) and 50% (v/v) Acetonitrile (ACN).  
 The sample was then analyzed on the 4700 Proteomics Analyzer Matrix-
Assisted Laser Desorption/Ionization Time-Of-Flight/Time-Of-Flight (MALDI/TOF-
TOF) (Applied Biosystems). MS data was automatically acquired in the reflectron 
mode by using the Reflectron Method which consisted of the exclusion list for most-
common trypsin and keratin peaks. Consequently, 10 most intense ions from Peptide 
Mass Fingerprinting (PMF) data were automated selected for further MS/MS 
fragmentation and analysis. The collision energy of the MS system was set at 1 KV 
and the collision gas used was nitrogen. 
 Protein identification was obtained by submitting MS and MS/MS data to the 
database search engine, MASCOT v 2.01 (Matrix Science Ltd., London, UK). A MS 
data search was conducted by using NCBI Database with the following parameter 
setting: all Entries were selected for taxonomy; Mass Error Tolerance of 150 ppm for 
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MS data and 0.2 Da for MS/MS data; Carbamidomethylation of Cysteine for fixed 
modification and Methionine Oxidation for variable modification. For data 
Interpretation purpose, GPS Explorer Software v 4.5 (Applied Biosystems) was used 
for the further data analysis.  
Modelling of NPAS1 
 A CLUSTALW alignment of bHLH-PAS domain proteins was submitted to 
SWISS-MODEL server (Schwede et al., 2003) to model the 3D structure of NPAS1 
using dPER (PDB id:1wa9A) as a template. ProModII running on the SWISS-
MODEL server first assigns a simple backbone, then it adds blocking groups and 
missing sidechains then it builds the non-conserved loops. The model is then further 
refined using a partial implementation of Gromos96, a molecular dynamics simulation 
program, is used to energy minimise the model. The final model is visualized using a 





NPAS1 immunofluorescence staining 
 Cryo-freezed brain sections of wild type SWISS albino mice embryos were 
used to perform immunofluorescence with NPAS1 antibodies. It was shown by Erber-
Sieler et al. (2004) that NPAS1 co-localises with GABA. It was shown by previous 
efforts in the lab that NPAS1 is upregulated in dopaminergic MN9D cells upon n-
butyrate treatment. It is of interest to investigate if there is a co-localisation of the 
NPAS1 protein with tyrosine hydroxylase (TH), the rate limiting enzyme of dopamine 
production. The NPAS1 antibodies used were from Ohsawa et al. (2005). Their group 
has successfully performed immunohistochemistry of NPAS1 in embryonic day 16.5 
(E16.5) old mice embryo (Ohsawa et al., 2005).  
 However, using the same antibodies the author did not manage to successfully 
label the NPAS1 molecule in the brain sections (see Figure 2). The antibodies were 
tested for viability through separate experiments in Western blots, and they proved to 
be viable for that application. Different concentrations of the antibody were used for 
immunofluorescence up to the maximum of 1:100 ratio. The fluorescence was 
however, weak and required very high laser intensity (in confocal microscopy) or post 
imaging adjustments of brightness (in fluorescence microscopy). Even with the 
adjustments, the level of fluorescence seemed uniform and is highly likely that it is 
due to background tissue autofluorescence. In contrast, TH antibodies show up in 
brain sections with a visibly higher level of fluorescence compared to the background 
tissue. Thus, the failure of the immunohistochemistry cannot be attributed to the poor 





Embryonic day 12.5 
 
 
Embryonic day 15.5 
 
 
Embryonic day 18.5 
 
Figure 2. Fluorescence images of the brain sections probed with NPAS1 and TH 
antibodies and fluorophore conjugated secondary antibodies.  
Plates A is the NPAS1 staining, plates B is the TH staining. Plates C is the overlap of 
the NPAS1 and TH staining. The embryonic stages are listed below the plates.  
 
 The reasons for the failed immunohistochemistry are unknown. It could be due 
to a combination of a lack of sensitivity of the antibodies due to age, and the low level 
of expression of the NPAS1 molecule in the various embryo stages tested. In a paper 
that attempts to address the developmental expression of another bHLH-PAS gene, 
clock, in the Syrian hamster using in situ hybridisation, radioactive probes were used 
(Li and Davis, 2005). Dr Davis’s team did not use non-radioactive probes largely due 
to a lack of experience and he feels that “High sensitivity is especially important for 
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developmental studies because low abundance seems likely at some age” (pers. 
comm.). 
 
Yeast one-hybrid assay to test for repressive activity  
NPAS1 was previously investigated by Teh (2006) to search for an 
autonomous transactivation domain using a modified yeast one-hybrid assay. The 
results were negative, hence a search was undertaken to investigate if NPAS1 
contained repression domain instead. This yielded results and subsequently NPAS1 
was reported by Ohsawa et al. (2005) to repress the expression of erythropoietin. The 
author has further expanded the study by further subdividing the NPAS1 protein into 
different deletion mutants in an effort to isolate parts of the molecule responsible for 
the repressive activity shown by NPAS1.  
The murine ARNT C-terminus was shown by Li and Whitlock (1994) to 
contain a transactivation domain. Thus a yeast one-hybrid assay was implemented 
using the 194 amino acid C-terminus of the ARNT molecule, fused to various deletion 
mutants to test the repression activity of the deletion mutants in order to map the 
region of repression. The parent plasmid was constructed by fusing the C-terminus of 
ARNT downstream of a LexA DNA binding domain (DBD). Deletion clones of 
NPAS1 were then fused downstream of the ARNT C-terminus. The resultant fusion 
protein is able to bind to LexA operators and as a result of the deletion clone that is 
fused to the protein, affect the activation of the lacZ reporter gene. 
A qualitative assay was first performed using beta-galactosidase as a reporter 
on X-Gal plates with SD/-UH (synthetic drop out medium with galactose/raffinose 
minus the amino acids uracil and histidine, as selection factors). 10-15 transformed 
colonies were picked per deletion clone and grown on X-Gal plates. The colour of the 
colonies on X-Gal plates for all of the picked colonies was verified to be uniform for 
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the same deletion clone. The results of this qualitative assay are shown schematically 
in Figure 3. The NPAS1 molecule was first subdivided into 4 parts: NPAS1 1-70 
(containing the basic motif of the bHLH protein), NPAS1 71-354 (containing part of the 
HLH motif of the bHLH motif and the PAS A and PAS B domain along with a 
polyserine region), NPAS1 348-507 (containing a PAC domain) and NPAS1 501-594 
(which just codes for the C-terminus of the NPAS1 molecule). It was established that 
only NPAS1 1-70 showed a lack of repression on the LexA ARNT C-terminus fusion.   
A second round of cloning was undertaken and this time NPAS1 71-354 was 
divided into two pieces NPAS1 71-165 (containing only part of the HLH domain and 
part of the PAS A domain) and NPAS1 166-354 (containing a polyserine region and 
most of the PAS B domain) and NPAS1 348-507 into two parts NPAS1 348-403 
(containing part of the PAS B domain and most of the PAC domain) and NPAS1 404-
507 (containing part of the end of the PAC domain). This time round, only NPAS1 404-
507 showed a lack of repressive ability. NPAS1 166-354 was further split into three parts 
NPAS1 166-205  (containing about half of the PAS A domain), NPAS1 206-290 
(containing the polyserine region and the linker region to PAS B domain) and NPAS1 
302-354 (containing most of the PAS B domain). NPAS1 166-205 was recalcitrant to 
cloning and hence unable to be tested for repressive activity, whilst NPAS1 206-290 
showed on X-Gal plates an intermediate colour change to blue and NPAS1 302-354 
showed a repressive activity on the transactivation domain of present in the C-
terminus of ARNT. The intermediate colour change for NPAS1 206-290 was 
consistently reproduced when the colonies were transferred to a fresh X-Gal plate. 
The results of the qualitative beta-galactosidase assay is summarised in Figure 3.  
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1st round NPAS1 1-70 NPAS1 71-354 NPAS1 348-507 NPAS1 501-594
2nd round NPAS1 71-165 NPAS1 166-354 NPAS1 348-403 NPAS1 404-507
3rd round NPAS1 166-205 NPAS1 206-290 NPAS1 302-354
 
 
Figure 3. Schematic showing the cloning steps of the deletion clones and the results of 
the qualitative assay for repression activity in yeast using beta-galactosidase as a 
reporter gene.  
The first numbers on the left denote the first, second and third round of cloning to 
achieve the different deletion clones. The first row represents the complete NPAS1 
molecule with the domains demarcated. The colours denote the result of the 
qualitative assay for repressive activity. The parent fusion construct of LexA ARNT 
C-terminus will activate the beta-galactosidase gene. On an X-Gal plate, the yeast 
colony will appear blue as a result. If the deletion clone fused downstream of this 
parent fusion protein has repressive activity, the colony will not turn blue. The 
corresponding deletion clone in this schematic is coloured blue if the clone has no 
repressive activity based on the colour change when the transformed EGY48 yeast is 
plated on an X-Gal plate. The deletion clone is coloured orange if it contains 
repressive activity. One of the deletion clones, NPAS1166-205 could not be cloned out 
and it is coloured white in the figure. Another of the deletion clone displayed a light 
blue colour on X-Gal plates. This clone, NPAS1206-290, is coloured light blue in the 
figure. 
Quantitative beta-galactosidase assay in yeast cells 
After the initial qualitative survey on the repressive activity of the various 
deletion clones of NPAS1 when fused to a LexA DBD-ARNT-C-terminus fusion 
construct. A quantitative beta-galactosidase assay was done on the lysates of the yeast 
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transformed with deletion constructs.  Three sets of data were collected from 
independent experiments to quantify the repression on the beta-galactosidase gene 
with the deletion mutants. Figure 4 shows the results of the experiments. 
Unfortunately, as a result of time restraint, only one set of data was obtained for full 






WB: LexA DBD  
Figure 4. Results of the repression assay using beta-galactosidase as a reporter in 
EGY48 yeast.  
The beta-galactosidase activity present in yeast cells containing LexA-ARNT C-
terminus fusion protein is compared to the yeast cells containing LexA-ARNT C-
NPAS1. The beta-galactosidase values are calculated as per the instructions in 
materials and methods and normalised to the beta-galactosidase activity in LexA-
ARNT C yeast cells. NPAS1 1-70 and NPAS1 404-507 show a trend towards a lack of 
repression activity. Whereas the rest of the deletion clones show a repressive effect on 
the transactivation domain present in the ARNT C-terminus. LexA NPAS1 fusion 
protein expression shown by Western blot. Results shown here is the mean of 3 
independent experiments with the S.E.M. shown as error bars. Unpaired two-tailed 
Student t-test was performed on the results. NPAS1 206-290 is significantly lower than 
the control for p < 0.05. NPAS1 71-165, NPAS1 302-354, NPAS1 348-403 and NPAS1 501-594 
are significantly lower than the control for p < 0.01.   
 
 The expression level of NPAS1 404-507 is noticeably lower than the rest as 
evidenced by the Western blot seen in Figure 4. Therefore its lack of repression 
activity has to be viewed in the context. On the other hand, the deletion mutant of 
NPAS1 206-290 showed a different result from the qualitative assay done earlier. The 
expression level of is NPAS1 206-290 relatively high in the qualitative beta-
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galactosidase assay. The colour of the yeast colonies on X-Gal plates is a lighter 
shade of blue compared to NPAS1 1-70 and NPAS1 404-507.  Transfer of the NPAS1 206-
290 colonies to a fresh plate using one NPAS1 1-70 as a comparison showed that this is 
not an anomaly belonging to the plate but a true reflection of the beta-gal activity. 
In the quantitative assay however, the NPAS1 206-290 deletion clone appears to 
have a significant repressive effect on transactivation domain of ARNT C-terminus 
based on the mean of three independent experiments. Nevertheless it should be noted 
that it has the lowest repressive strength of the deletion clones.  
NPAS1 302-354 and NPAS1 348-403 showed repression of the transactivation 
domain in the yeast beta-gal assay however when the same deletion mutants were 
examined using luciferase assay in HEK293 cells, NPAS1 302-354 and NPAS1 348-403 
did not significantly repress luciferase activity.  
Luciferase assay for repression activity 
The deletion clones were tested for repression activity in another eukaryotic 
system, to further verify the results and to investigate if NPAS1 repression might be 
attenuated in different eukaryotic systems. The latter might arise from post-
translational modification unique to the cell. MN9D and HEK293 were chosen for 
this experiment. MN9D cells are dopaminergic in nature and it was in MN9D cells 
that NPAS1 was identified as involved in the N-butyrate differentiation of MN9D 
cells. HEK293 cells were also used in the study by Ohsawa et al. (2005) to show that 
murine NPAS1 represses EPO. Deletion clones of NPAS1 were fused to a GAL4 
DNA binding domain (DBD) in the parent plasmid of pM. Firefly luciferase under the 
control of Tk promoter with four upstream GAL4 binding sites, formed the reporter 
plasmid. Another plasmid containing the Renilla luciferase acts as the internal control 
which can normalise the firefly luciferase results to transfection efficiency and cell 
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number differences. Unfortunately, MN9D cells showed results that seemed 
unreliable, with luminometer values that were very close to the background 
luminosity (see appendix). In a separate experiment which required the transfection of 
MN9D cells with GFP tagged NPAS1 showed a lower level of expression than usual. 
It is suspected that the high number of passages for the MN9D cells caused the 
unreliable results. The results for HEK293 by comparison were more reliable and the 




Figure 5. Results for test of repression activity for deletion clones of NPAS1. 
HEK293 cells were transfected with a series of GAL4 plasmids expressing NPAS1 
deletion mutants together with reporter plasmid pGAL4 TK Luc and internal control 
plasmid pRL SV40.  
Protein lysates were collected from these transfected cells for Dual-Luciferase assay 
as described in Materials and Methods. Lane a: lysate of HEK293 cells transfected 
with pM, a GAL4 DBD expressing plasmid as control. Lane b: lysate of HEK293 
cells transfected with GAL4 NPAS1 1-70. Lane c: GAL4  NPAS1 71-165. Lane d: GAL4  
NPAS1 206-290. Lane e: GAL4  NPAS1 302-354. Lane f: GAL4  NPAS1 348-403. Lane g: 
GAL4  NPAS1 404-507. Lane h: GAL4  NPAS1 501-594. The three deletion mutants, 
NPAS1(71-165), NPAS1(206-290) and NPAS1(501-594) were able to repress the level of 
reporter gene.  The luc level shown here is normalized to the internal control Renilla 
luciferase (Rluc). Western blot was done for using GAL4 antibodies to show the 
expression of the deletion mutants. Data shown as mean with S.E.M. of three 
independent experiments. The statistical significance of the differences was calculated 
using an unpaired two-tailed Student t-test: for *p < 0.01. 
 
In vitro interaction between NPAS1 and ARNT  
 ARNT and ARNT2 are known to form heterodimers with other PAS domain 
proteins. ARNT is commonly accepted as a generic transcription factor (Swanson et 
al., 1995) that dimerizes with the AhR and other bHLH/PAS proteins (Wang et al., 
1995). For example a search on BIND (Biomolecular Interaction Network Database) 
(Alfarano et al., 2005) revealed that ARNT forms heterodimers with AhR, HIF-1α, 
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SIM1 and EPAS1. ARNT2 forms heterodimers with SIM2. ARNT3/BMAL1 forms 
heterodimers with CLOCK, HIF-1α. So an investigation was carried out to determine 
if ARNT is an interactor with NPAS1. Initially, fl ARNT and fl NPAS1 was 
expressed separately in bacterial hosts and beads incubated in one lysate were used to 
pull down the putative interacting partner. However, the interaction was too weak to 
be regarded as a specific affinity between both proteins. It turned out that Chachami et 
al. (2005) faced a similar situation when testing for the interaction between HIF-1α 
and ARNT.  They had solved the problem by co-expressing the two proteins in a 
single bacteria host using double antibiotic selection. A similar approach was then 
undertaken for NPAS1 and ARNT. Full-length NPAS1 was cloned into a pGEX4T-1 
vector which fused NPAS1 with a GST tag that can be pulled down by Glutathione 
Sepharose™ beads.  Full-length ARNT was cloned into a pMalc2x which fused 
ARNT with a MBP tag which can be pulled down by amylose beads. Both vectors 
were co-transformed into a BL21 E. coli host and ampicillin and kanamycin antibiotic 
resistance was used to select for co-transformants. Controls were made to ensure that 
the in vitro interaction is not due to interaction on the tag. Three other co-
transformants consisting of all possible combinations of the MBP and GST tags and 
tagged fl ARNT & fl NPAS1 were made. Figure 7 shows the expression of MBP tags 
and MBP fl ARNT in the bacterial lysate using anti-MBP antibodies.  Figure 8 shows 
the 4th elution fraction of the MBP pull down experiment containing only GST fl 
NPAS1 lane D. Lanes A and C did not show GST tag being pulled down by either 
MBP tag or MBP fl ARNT respectively and lane B did not show GST fl NPAS1 
being pulled down by MBP fl ARNT. To ensure that it is MBP fl ARNT that is 
pulling down the bacterially expressed GST fl NPAS1, the blot from Figure 3 was 
stripped with stripping buffer for 13 min and probed with anti-MBP antibodies. The 
resultant blot is shown as Figure 9.  
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Figure 6. GST tag and GST tagged fl NPAS1 expressed in the double transformed 
bacteria host.  
Similar to the MBP WB. However, the lysates are probed with anti-GST antibodies 
here. (A: MBP & GST, B: MBP & GST fl NPAS1, C: MBP fl ARNT & GST and D: 
MBP fl ARNT & GST fl NPAS1). The “empty” space in the GST bands is a result of 
the high levels of the GST present which in turn binds the antibodies in large 
amounts. The chemiluminescence substrate is used up very quickly resulting in an 
“empty” space where the bands are the strongest. 
 
 
Figure 7. MBP tag and MBP tagged fl ARNT are expressed in the double transformed 
bacteria host.  
The double transformed bacteria are screened for expression of the MBP tag and 
MBP tagged fl ARNT. 3 clones were chosen from each double transformed bacteria 
(A: MBP & GST, B: MBP & GST fl NPAS1, C: MBP fl ARNT & GST and D: MBP 
fl ARNT & GST fl NPAS1). The first clones were chosen for the subsequent pull 





Figure 8. In vitro pull down of bacterially expressed murine NPAS1 with MBP beads. 
The blot was probed with GST antibodies to view the results of the pull down.  
Lane A: pull down with lysate of bacteria co-transformed with GST tag containing 
plasmid and MBP tag containing plasmid. Lane B: pull down with lysate of bacteria 
co-transformed with GST-fl NPAS1 containing plasmid and MBP tag containing 
plasmid. Lane C: pull down with lysate of bacteria co-transformed with GST tag 
containing plasmid and MBP-fl ARNT containing plasmid. Lane D: pull down with 
lysate of bacteria co-transformed with GST-fl NPAS1 containing plasmid and MBP -
fl ARNT containing plasmid. Only the GST tagged fl NPAS1 was pulled down with 
MBP beads after washing with 5% Triton X-100 in PBS ten times and one time with 
elution buffer containing 10 mM maltose. The control double transformants with the 
GST tag show that MBP and MBP fl ARNT do not pull down the 25 kDa GST tag. 
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Figure 9. Western blot from MBP pull down. The blot in Figure 8. was stripped of 
GST antibodies and probed with anti-MBP antibodies.  
The lanes denote the lysate of the double transformed bacteria used (A: MBP & GST, 
B: MBP & GST fl NPAS1, C: MBP fl ARNT & GST and D: MBP fl ARNT & GST 
fl NPAS1). MBP tag and MBP fl ARNT are both pulled down by amylose beads and 




Figure 10. Western blot of the in vitro pull down of MBP fl ARNT by GST fl NPAS1 
using GST beads.   
A: MBP & GST, B: MBP & GST fl NPAS1, C: MBP fl ARNT & GST and D: MBP 
fl ARNT & GST fl NPAS1. The pull down by GST beads still needs optimisation to 
remove the MBP binding to GST and GST fl NPAS1.  
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From Figure 10 it can be seen that there is still binding of MBP fl ARNT with GST fl 
NPAS1. But the specificity of this binding is not absolutely certain, as the MBP tag 
appears to bind to GST and GST fl NPAS1. However, it must be noted that the 
expression levels of the 50 kDa MBP tag is very much higher than the tagged full-
length proteins. An extreme example is seen in Figure 6 where the GST band is so 
strong that it uses up the chemiluminescence substrate very quickly, leaving a “hole” 
where the GST band is. Thus it is likely that the binding presented in Figure 10 is 
specific rather than an affinity of MBP for GST and GST fl NPAS1.   
In vivo pull down with FLAG tagged NPAS1 
 An immunoprecipitation experiment was carried out to identify any co-
repressors with NPAS1. Two independent immunoprecipitations were carried out. 
The immunoprecipitation results were visualized by silver staining and Coomassie 
stain separately. The gels can be seen in Figures 11 and 12 respectively. The results of 
the identification of the bands using MALDI/TOF-TOF are tabulated in Tables 2 and 
3. Two proteins turned up in both sets of results, they are heat shock 90kDa protein 
(HSP90) (gi|20149594) and heat shock 70kDa protein (HSP70) (gi|55962553). For the 
silver staining set of results, other meaningful results include TUBB 
protein(gi|12804891) and ADP/ATP carrier protein (adenine nucleotide translocator 
2) (gi|2772564). The Coomassie stain set of results provided more interesting results 
like tyrosine 3/tryptophan 5 -monooxygenase activation protein, epsilon polypeptide 






Figure 11. In vivo immunoprecipitation in HEK293 cells to search for NPAS1 
interacting partners. M2 beads were used to pull down transiently expressed FLAG 
tagged NPAS1 in HEK293 cells.  
The beads were incubated with cell lysate transfected with fl NPAS1, C-terminus of 
NPAS1 and N-terminus of NPAS1 separately. The beads were then washed for 
unspecific binding and loaded onto a 1-D SDS PAGE. The gel was silver-stained and 
specific binding bands were cut out for MALDI TOF-TOF analysis. The bands were 
labelled according to whether it binds fl NPAS1 (F), N-terminus of NPAS1 (N) or C-
terminus of NPAS1 (C). The first two lanes after the ladder is the pull down from 
control FLAG expressing cells. The third to sixth lanes is the pull down from fl 
NPAS1, the seventh to tenth lanes is the pull down from N-terminus of NPAS1, the 





Figure 12. 2nd in vivo immunoprecipitation in HEK293 cells to search for NPAS1 
interacting partners.  
Coomassie stained 1D PAGE of the proteins pulled down by A: FLAG, B: FLAG fl 
NPAS1, C: FLAG N-terminus NPAS1, D: FLAG C-terminus NPAS1. 9 bands were 
first selected from the gel and they were labelled 1-9 in the figure. The bands that 
were cut all bound the full-length, N-terminus and C-terminus of NPAS1, hence the 
nomenclature used in Figure 11 was not used here. Only bands 1, 2, 4, 5, 7, 8 and 9 
were further processed. Some of the bands whose identity was found in the 1st 
immunoprecipitation to belong to housekeeping genes were not processed again.  
Bands that were not pulled down by the full-length proteins were deemed as false 
positives and not investigated. 
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Table 2. Results of the identification of the bands from the first immunoprecipitation 
done on the silver stained gel with FLAG fl NPAS1, N-terminus of NPAS1 and C-
terminus of NPAS1 in HEK293 cells.  
Ions score is -10*Log( p ), where p is the probability that the observed match is a 
random event. Protein scores greater than 77 are significant ( p <0.05). 
 
Band Hit Accession Mass Score Description 
1 gi|6679100 63982 560 Neuronal PAS domain protein 1 [Mus musculus] 
2 gi|62639064 64223 410 PREDICTED: similar to neuronal PAS1 [Rattus norvegicus] 
3 gi|1840056 63053 217 Neuronal PAS1 [Homo sapiens] 
4 gi|22027482 63005 217 Neuronal PAS domain protein 1 [Homo sapiens] 
5 gi|55649473 76672 205 PREDICTED: hypothetical protein XP_512776 [Pan troglodytes] 
6 gi|27371247 71372 204 Hsc70-prov protein [Xenopus laevis] 
7 gi|28374367 70976 198 MGC53952 protein [Xenopus laevis] 
8 gi|74186087 70967 197 Unnamed protein product [Mus musculus] 
9 gi|74142040 71069 197 Unnamed protein product [Mus musculus] 
F1 
10 gi|73954623 67925 197 PREDICTED: similar to heat shock cognate 71 kDa protein (heat 
shock 70 kDa protein 8) isoform 4 [Ca 
 1 gi|780265 17679 149 Ig gamma-1 heavy chain [Mus musculus] 
2 gi|5114265 48796 134 Gamma1 heavy chain of Mab7 [Mus musculus] 
3 gi|7439167 50118 134 Monoclonal antibody 13-1 heavy chain - mouse (fragment) 
4 gi|14091948 36288 133 Immunoglobulin heavy chain constant region [Mus musculus domesticus] 
5 gi|195162 36273 133 Stop codon and following 6 bases deleted; putative 
6 gi|14198347 52125 132 Igh-4 protein [Mus musculus] 
7 gi|14091947 39113 132 Immunoglobulin heavy chain constant region [Mus musculus domesticus] 
8 gi|74190484 52242 132 Unnamed protein product [Mus musculus] 









10 gi|440121 51545 130 Immunoglobulin gamma-chain 
 1 gi|74204140 50072 415 Unnamed protein product [Mus musculus] 
2 gi|74141821 50123 413 Unnamed protein product [Mus musculus] 
3 gi|57491330 50118 403 GekBS060P [Gekko japonicus] 
4 gi|338695 50240 403 Beta-tubulin 
5 gi|47221548 50111 403 Unnamed protein product [Tetraodon nigroviridis] 
6 gi|74223737 50108 403 Unnamed protein product [Mus musculus] 
7 gi|37681975 50097 403 Tubulin, beta 5 [Danio rerio] 
8 gi|49250860 50152 403 Tubulin, beta, 5 [Xenopus tropicalis] 
9 gi|7106439 50095 403 Tubulin, beta 5 [Mus musculus] 
F3 
10 gi|76650558 48255 402 PREDICTED: similar to tubulin, beta 5 isoform 4 [Bos taurus] 
 1 gi|12082134 82254 325 Heat shock protein 90 beta [Equus caballus] 
2 gi|55731477 83528 324 Hypothetical protein [Pongo pygmaeus] 
3 gi|51859516 83631 323 Heat shock 90kDa protein 1, beta [Rattus norvegicus] 
4 gi|20149594 83554 323 Heat shock 90kDa protein 1, beta [Homo sapiens] 
5 gi|37142918 83527 323 Heat shock protein 90 [Equus caballus] 
6 gi|40556608 83571 323 Heat shock protein 1, beta [Mus musculus] 
7 gi|6807647 85189 321 Hypothetical protein [Homo sapiens] 
8 gi|194027 83522 315 Heat-shock protein hsp84 
9 gi|74147026 83513 315 Unnamed protein product [Mus musculus] 
FN1 
10 gi|306891 83584 313 90kDa heat shock protein 
 1 gi|12804891 38690 91 TUBB protein [Homo sapiens] 
2 gi|74204140 50072 91 Unnamed protein product [Mus musculus] 
3 gi|57209814 42114 91 Tubulin, beta polypeptide [Homo sapiens] 
4 gi|74275413 33700 87 Beta-tubulin [Sesamia nonagrioides] 
5 gi|72020788 36531 85 PREDICTED: similar to tubulin, beta, 2, partial [Strongylocentrotus purpuratus] 
6 gi|16198437 30625 84 TUBB protein [Homo sapiens] 
7 gi|76650560 50267 84 PREDICTED: similar to tubulin, beta 5 isoform 5 [Bos taurus] 
8 gi|47221548 50111 83 Unnamed protein product [Tetraodon nigroviridis] 
9 gi|12846758 50064 83 Unnamed protein product [Mus musculus] 
FN2 
10 gi|74223737 50108 83 Unnamed protein product [Mus musculus] 
 
1 gi|42573598 49896 68 Clathrin adaptor complexes medium subunit family protein [Arabidopsis thaliana] 




3 gi|47564942 64569 66 S-layer homology domain [Bacillus cereus G9241] 
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4 gi|69930212 30080 64 Short-chain dehydrogenase/reductase SDR [Nitrobacter hamburgensis X14] 
5 gi|48782968 8311 62 Hypothetical protein Bcep02005943 [Burkholderia fungorum LB400] 
6 gi|3738144 54025 62 SPBC1709.06 [Schizosaccharomyces pombe] 
7 gi|4376057 20709 61 Actin [Oreochromis mossambicus] 
8 gi|21219996 18296 61 Shikimate kinase I [Streptomyces coelicolor A3(2)] 
9 gi|50309321 30305 60 Unnamed protein product [Kluyveromyces lactis] 
 
10 gi|9758499 49747 59 AP47/50p [Arabidopsis thaliana] 
 
1 gi|6729803 41973 154 Chain A, Heat-Shock 70kd Protein 42kd ATPase N-Terminal Domain 
2 gi|42543698 42189 154 Chain A, The Crystal Structure Of The Human Hsp70 ATPase Domain 
3 gi|62089222 78018 144 Heat shock 70kDa protein 1A variant [Homo sapiens] 
4 gi|386785 70110 143 Heat shock protein 
5 gi|55962553 70294 143 Heat shock 70kDa protein 1B [Homo sapiens] 
6 gi|4529893 70280 143 HSP70-1 [Homo sapiens] 
7 gi|4529892 70267 143 HSP70-2 [Homo sapiens] 
8 gi|61372081 70407 143 Heat shock 70kDa protein 1A [synthetic construct] 
9 gi|6679100 63982 140 Neuronal PAS domain protein 1 [Mus musculus] 
FN4 
10 gi|32813265 70312 134 Heat shock protein 70 [Canis familiaris] 
 
1 gi|76260960 46397 71 Glucose-1-phosphate adenylyltransferase [Chloroflexus aurantiacus J-10-fl] 
2 gi|66522502 71084 65 PREDICTED: similar to MGC83680 protein [Apis mellifera] 
3 gi|1405615 197202 62 Putative replicase [Grapevine virus A] 
4 gi|54639172 112698 61 GA14499-PA [Drosophila pseudoobscura] 
5 gi|53728471 33588 60 COG1561: Uncharacterized stress-induced protein [Haemophilus somnus 2336] 
6 gi|148204 34889 59 Porphobilinogen deaminase [Escherichia coli] 
7 gi|54298523 21761 59 Hypothetical protein lpp2587 [Legionella pneumophila str. Paris] 
8 gi|54023552 28768 59 Putative transcriptional regulator [Nocardia farcinica IFM 10152] 




10 gi|27904144 26719 59 Orotidine 5'-phosphate decarboxylase [Buchnera aphidicola str. Bp (Baizongia pistaciae)] 
 
1 gi|2772564 33059 102 ADP/ATP carrier protein (adenine nucleotide translocator 2) [Homo sapiens] 
2 gi|45829841 35499 101 SLC25A5 protein [Homo sapiens] 
3 gi|74008184 27931 101 PREDICTED: similar to ADP/ATP translocase 2 (Adenine 
nucleotide translocator 2) (ANT 2) (ADP,ATP ca 
4 gi|74355032 33162 100 Solute carrier family 25 member 5 [Bos taurus] 
5 gi|4502099 33102 100 Solute carrier family 25, member 5 [Homo sapiens] 
6 gi|22094075 33138 100 Solute carrier family 25, member 5 [Mus musculus] 
7 gi|37590229 33108 100 Solute carrier family 25, member 5 [Rattus norvegicus] 
8 gi|74008196 33224 100 PREDICTED: similar to solute carrier family 25, member 5 isoform 1 [Canis familiaris] 
9 gi|74008190 33422 100 PREDICTED: similar to solute carrier family 25, member 5 isoform 6 [Canis familiaris] 
FNC2 
10 gi|74008188 32780 100 PREDICTED: similar to solute carrier family 25, member 5 isoform 5 [Canis familiaris] 
 1 gi|6679100 63982 113 Neuronal PAS domain protein 1 [Mus musculus] 
2 gi|62639064 64223 83 PREDICTED: similar to neuronal PAS1 [Rattus norvegicus] 
3 gi|22027482 63005 71 Neuronal PAS domain protein 1 [Homo sapiens] 
4 gi|1840056 63053 65 Neuronal PAS1 [Homo sapiens] 
5 gi|48786611 58703 61 COG0069: Glutamate synthase domain 2 [Burkholderia fungorum LB400] 
6 gi|4151871 13215 59 Nonstructural protein 1 [Aleutian mink disease virus] 
7 gi|49257941 77542 59 Interleukin enhancer binding factor 3, 90kDa [Xenopus tropicalis] 
8 gi|55649473 76672 58 PREDICTED: hypothetical protein XP_512776 [Pan troglodytes] 
9 gi|76641882 62542 58 PREDICTED: similar to neuronal PAS domain protein 1 [Bos taurus] 
N1 
10 gi|68402694 50225 58 PREDICTED: similar to tubulin, beta, 2 isoform 1 [Danio rerio] 
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Table 3. Results of the identification of the bands from the second 
immunoprecipitation done on the Coomassie stained gel with FLAG fl NPAS1, N-
terminus of NPAS1 and C-terminus of NPAS1 in HEK293 cells.  
Ions score is -10*Log( p ), where p is the probability that the observed match is a 
random event. Protein scores greater than 77 are significant ( p <0.05). 
 
Band Hit Accession   Mass   Score Description 
1  gi|12082134   82254 695 Heat shock protein 90 beta [Equus caballus] 
2  gi|51859516   83631 693 Heat shock 90kDa protein 1, beta [Rattus norvegicus] 
3  gi|20149594   83554 693 Heat shock 90kDa protein 1, beta [Homo sapiens] 
4  gi|37142918   83527 693 Heat shock protein 90 [Equus caballus] 
5  gi|34392345   83543 693 90-kDa heat shock protein beta [Bos taurus] 
6  gi|40556608   83571 693 Heat shock protein 1, beta [Mus musculus] 
7  gi|55731477   83528 693 Hypothetical protein [Pongo pygmaeus] 
8  gi|306891   83584 692 90kDa heat shock protein 
1 
9  gi|6807647   85189 691 Hypothetical protein [Homo sapiens] 
 1  gi|55962553   70294 918 Heat shock 70kDa protein 1B [Homo sapiens] 
2  gi|4529893   70280 918 HSP70-1 [Homo sapiens] 
2 
3  gi|4529892   70267 918 HSP70-2 [Homo sapiens] 
 1  gi|23452398   50250 493 Class I beta tubulin [Danio rerio] 
2  gi|47221548   50111 493 Unnamed protein product [Tetraodon nigroviridis] 
3  gi|74141821   50123 493 Unnamed protein product [Mus musculus] 
4  gi|74204140   50072 493 Unnamed protein product [Mus musculus] 
4 
5  gi|74223737   50108 493 Unnamed protein product [Mus musculus] 
 
 Synonyms 48-kDa TATA box-binding protein-interacting protein, 48-kDa TBP-interacting protein, 51 kDa 
erythrocyte cytosolic protein, CGI-46, ECP51, ECP-51, Repressing pontin 52, Reptin 52, RuvB-
like 2, TAP54-beta, TIP48, TIP49b, TIP49B, TIP60-associated protein 54-beta 
1  gi|74183123   51283 792 Unnamed protein product [Mus musculus] 
2  gi|67678298   51286 792 RuvB-like 2 [Rattus norvegicus] 
3  gi|76641945   51282 792 PREDICTED: similar to RuvB-like 2 (48-kDa TATA box-binding protein 
interacting protein) (48-kDa TBP 
4  gi|5730023   51296 792 RuvB-like 2 [Homo sapiens] 
5 
5  gi|6755382   51252 792 RuvB-like protein 2 [Mus musculus] 
 1  gi|12850141   38845 703 Unnamed protein product [Mus musculus] 
2  gi|73996520   33685 700 PREDICTED: similar to Tubulin alpha-6 chain (Alpha-tubulin 6) (Alpha-
tubulin isotype M-alpha-6) iso 
3  gi|73996530   46555 693 PREDICTED: similar to Tubulin alpha-6 chain (Alpha-tubulin 6) (Alpha-
tubulin isotype M-alpha-6) iso 
4  gi|73996522   48863 690 PREDICTED: similar to Tubulin alpha-2 chain (Alpha-tubulin 2) isoform 7 
[Canis familiaris] 
5  gi|76618159   48221 689 PREDICTED: similar to Tubulin alpha-2 chain (Alpha-tubulin 2) isoform 
14 [Bos taurus] 
6  gi|74198443   50592 688 Unnamed protein product [Mus musculus] 
7  gi|73996516   50562 688 PREDICTED: similar to Tubulin alpha-2 chain (Alpha-tubulin 2) isoform 2 
[Canis familiaris] 
8  gi|6678469   50562 688 Tubulin, alpha 6 [Mus musculus] 
9  gi|90217   50748 688 Tubulin alpha-3 chain - Chinese hamster 
7 
10  gi|13435888   39259 688 Tuba2 protein [Mus musculus] 
 1  gi|49868   39446 485 Putative beta-actin (aa 27-375) [Mus musculus] 
2  gi|45269029   45162 437 Cytoskeletal beta actin [Sus scrofa] 
3  gi|73964667   42053 436 PREDICTED: hypothetical protein XP_533132 [Canis familiaris] 
4  gi|74213524   42066 434 Unnamed protein product [Mus musculus] 
5  gi|6716561   41990 433 Beta-actin [Rivulus marmoratus] 
6  gi|8886013   42012 433 Beta-actin [Oncorhynchus mykiss] 
7  gi|1703127   42163 426 Actin, cytoplasmic type 8 
8  gi|15277503   40536 425 ACTB protein [Homo sapiens] 
9  gi|47218950   42890 425 Unnamed protein product [Tetraodon nigroviridis] 
10  gi|576368   42143 425 Chain A, Beta-Actin-Profilin Complex 
8 
11  gi|74187644   42053 424 Unnamed protein product [Mus musculus] 
 1  gi|13928824   29274 217 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein [Rattus norvegicus] 
9 
2  gi|30584583   29440 216 Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, epsilon polype 
 51 
3  gi|73960520   26785 213 PREDICTED: similar to 14-3-3 protein epsilon (14-3-3E) (Mitochondrial 
import stimulation factor L s 
4  gi|73960518   24194 212 PREDICTED: similar to 14-3-3 protein epsilon (14-3-3E) (Mitochondrial 
import stimulation factor L s 
5  gi|67464424   26912 212 Chain A, 14-3-3 Protein Epsilon (Human) Complexed To Peptide 
6  gi|73967154   27573 211 PREDICTED: similar to 14-3-3 protein epsilon (14-3-3E) (Mitochondrial 
import stimulation factor L s 
7  gi|31981925   29341 211 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, epsilon polypeptide [Mus mu 
8  gi|5803225   29326 211 Tyrosine 3/tryptophan 5 -monooxygenase activation protein, epsilon 
polypeptide [Homo sapiens] 
9  gi|60416167   29012 206 Hypothetical protein LOC503763 [Danio rerio] 
10  gi|62901906   32173 205 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, epsilon polypeptide [synthe 
11  gi|530049   26450 203 14-3-3 protein 
12  gi|62131678   26658 203 14-3-3 protein epsilon isoform transcript variant 1 [Homo sapiens] 
13  gi|55824574   22662 200 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein epsilon isoform [Macaca fasc 
 




Regions responsible for repressive activity in the NPAS1 molecule 
 It was established by Teh (2006) that the N-terminus and C-terminus of NPAS1 
contains repression activity. This study attempts to further delineate the repressive 
elements present in the NPAS1 molecule through smaller deletion clones.  
 It was unfortunate that one region of the NPAS1 molecule (amino acids 166-205) 
was recalcitrant to cloning. This region has a GC percentage of 60.17% versus 41% 
which is reported as the average GC content of mammalian genes (Lander et al., 
2001). Optimisation steps include changing the PCR conditions at annealing 
temperature to as low as 50 °C. Q buffer (Qiagen) was used as well to help in the PCR 
of the GC rich region. However, the region still cannot be cloned. The repressive 




 Figure legend =  
 
Figure 13. Schematic showing the NPAS1 fragments containing different domains 
and motifs.  
Nomenclature of the motifs is according to the CDD database at NCBI. PAS 1 is 
equivalent to PAS A in the main text; PAS 2 is PAS B in the main text. PAC is a PAS 
domain associated C-terminal motif. Note that the region for amino acids 71-165 was 
unable to be cloned out.  
 
  NPAS1 71-165, NPAS1 206-290 and NPAS1 501-594 are the three deletion clones which 
have shown repressive ability consistently in both the beta-gal assay conducted in 
yeast and luciferase assay conducted in HEK293 cells. Figure 13 shows the schematic 
of the important motifs that each deletion clone contains. Mammalian cell lines 
MN9D and HEK293 cells were chosen for the experiment, because the investigation 
of the murine NPAS1 deletion clones' repressive activity would be more suitable in a 
mammalian cell line. The results of the of the yeast beta-galactosidase assay needs to 
be verified as well, as it seems unlikely that only two regions of the NPAS1 molecule 
show a lack of repression. Co-repressors present in mammalian cells might make the 
repression assay more physiologically relevant.  The more suitable MN9D cell line 
was initially chosen for the luciferase experiments. The results however were 
unreliable as the luminosity of the cell lysate was very low. Furthermore, the values 
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were close to the background reading on the luminometer. The expression of the 
fusion protein is suspected to be poor.  
 Large number of cell passages resulting in the instability of the MN9D cell line, 
was presumed to be the cause of this poor expression. In a separate experiment where 
GFP tagged NPAS1 was expressed in MN9D cells, revealed a visibly lower than 
usual expression viewed with a fluorescence microscopy (data not shown). Hence 
HEK293 was used as an alternative. HEK293 cells have also been used in the 
experiments by Ohsawa et al. (2005) to show the repression of EPO by murine 
NPAS1. Furthermore, NPAS1 appears to be not limited in expression to neuronal cell 
lines, despite it being named as neuronal PAS domain protein 1. The name arose as it 
was first reported by Zhou et al. (1997) that in situ hybridization assays showed an 
exclusive neuronal pattern of NPAS1 expression in postnatal mice. Teh (2006) 
showed through a more sensitive technique of Western blots of various tissue lysate 
of embryonic mice, that NPAS1 can be found in other tissues. The inability for the 
author's immunofluorescence labelling of the NPAS1 molecule in embryonic brain 
sections, also hint at the possible low levels of NPAS1 expression in embryonic mice. 
Thus there is no reason to suspect that NPAS1's expression and effect is limited to 
neuronal cell lines like MN9D, making HEK293 an unsuitable cell line for luciferase 
assay.  
 Assay for repressive activity of the truncated clones in yeast showed different 
results from the luciferase assay in HEK293 cells. NPAS1 302-354 and NPAS1 348-403 
which had showed significant repressive activity in the beta-galactosidase assay in 
yeast, did not show significant repressive activity in the luciferase assay in HEK293 
cells. It is likely that post-translational events play a role in this discrepancy. 
Comparing the Western blot of the LexA ARNT C fusion protein and the GAL4 
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fusion proteins, the level of expression of the fusion proteins differ. This hints at a 







Figure 14. Two views of the SWISS-MODEL predicted structure of NPAS1.  
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Top plate shows the molecule from N-terminus to C-terminus (left to right). Bottom 
plate shows the back view. The part of the molecule highlighted in red is amino acids 
141-165 of the NPAS1. The region from amino acids 71-140 is not modelled as only 
part of the dPER has structural data. Thus the red region represents the N-terminus 
region of repression. The green region is amino acids from 206-290, another region of 
repression, which represents the linker region. In this structure it is seen to form part 
of the PAS A domain fold and a pair of helices that extend out of the molecule. The 
third region of repression is the C-terminus beyond the dPER fragment whose 
structure was solved. Therefore, it cannot be visualised on this predicted model. 
 
 NPAS1 71-165 contains part of the HLH motif and part of the PAS A domain. As 
the HLH is not present in the dPER molecule, the HLH motif is not presented in 
Figure 14. Only amino acids 141-165 of NPAS1 are modelled and it is highlighted in 
red in Figure 14. 
 NPAS1 206-290 is the linker region bridging the two PAS domains. The stretch of 
sequence (199-244) in NPAS1 surrounding the polyserine residues is not duplicated 
in the dPER. The theoretical model by SWISS-MODEL, predicts this stretch as two 
tandem helices which project out of the molecule. One of the interesting features in 
this region is a stretch of 7 poly serine residues starting from amino acids 214 to 223. 
This poly serine region is only duplicated with modifications in murine NPAS3 
(amino acids 236-244). The stretch of poly serine with a sequence of SSASSSSQS is 
interrupted by a small alanine and a polar glutamine residue. This peptide sequence is 
still mainly comprised of polar amino acids with the exception of alanine. 
Interestingly, the alpha-helix secondary structure is interrupted by part of the poly 
serine stretch and in the dPER X-ray diffraction data there are missing residues (295-
306 of dPER) in the same region where the helical secondary structure is predicted. 
The sequence of this linker region is not conserved across other bHLH-PAS proteins, 
nor is its length constant (see Table 4.). Variations in this region might be the cause 
for the differing action of different bHLH-PAS proteins.  
 Another striking feature of the linker regions examined in the bHLH-PAS proteins 
are that the 'generic' dimerization partner (like ARNT, ARNT2, ARNT3/BMAL1 
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(CYCLE in Drosophila) have the longest linker lengths. Examining the linker lengths 
of the murine dimer pair of CLOCK and BMAL1 with the Drosophila homolog of 
CLOCK and CYCLE, there is an increase of ten amino acids for the CLOCK 
homologs (85 vs. 95) with a concomitant increase of 11 amino acids for the 
BMAL1/CYCLE homologs (111 vs. 122). This suggests a possible conservation of 
linker length based on the dimer pairings. Although the final folded form of the 
deletion clone might vary from the original molecule, the deletion clone still 
possesses repression activity when fused to a DBD. Based on the theoretical model 
shown in Figure 14, the linker region is depicted as a pair of tandem helices projecting 
out of the NPAS1 molecule. The linker region might have repression activity as a 
result of an association with the dimer partner. However, this hypothesis is highly 
speculative. It is just as possible that this linker region is important for environmental 
sensing, taking into account that the trigger for the activation of NPAS1 is not exactly 
known. Unlike the AhR which senses dioxin whose minimal ligand binding domain 
has been identified to amino acids 230 to 431 (Coumailleau et al., 1995). This 
fragment of AhR contains the PAS B domain flanked by part of the linker region and 
part of the C-terminus of AhR. This minimal ligand binding domain is able to bind 
HSP90. 
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Table 4. Table comparing the lengths of the PAS A, PAS B, PAC and linker regions of 
some of the bHLH-PAS proteins.  
The paralogs appear to retain similar domain lengths. Strikingly, the 'generic' 
dimerization partners like ARNT, ARNT2, ARNT3/BMAL1 (CYCLE in 
Drosophila), have the longest linker regions of them all. * For the murine SIM2, the 











PER3_MOUSE O70361 67 71 69 41 
PER2_MOUSE O54943 67 71 71 41 
PER1_MOUSE O35973 67 71 71 41 
SIM1_MOUSE Q61045 71 71 71 41 
SIM2_MOUSE Q61079 71 71 71 71* 
HIF1A_MOUSE Q61221 76 71 73 14 
PER_ANTPE Q17062 71 71 75 41 
PER_DROVI P12349 71 71 80 41 
PER_DROME P07663 71 71 80 41 
CLOCK_MOUSE O08785 71 71 85 13 
NPAS2_MOUSE P97460 71 71 85 41 
NPAS1_HUMAN Q99742 73 67 86 44 
NPAS1_MOUSE P97459 71 67 89 44 
AHR_MOUSE P30561 64 68 90 39 
CLOCK_DROME O61735 73 67 95 0 
NPAS3_MOUSE Q9QZQ0 71 71 102 44 
BMAL1_MOUSE Q9WTL8 73 71 111 44 
ARNT_MOUSE P53762 75 71 114 44 
ARNT2_MOUSE Q61324 76 71 114 44 




 NPAS1 501-594 is the C-terminus of NPAS1. Of all the regions tested, this fragment 
has consistently the highest repressive effect.  However, it does not contain any 
known motif or domain. Comparing to full-length HIF-1α (826 amino acids long), 
deletion of the carboxyl terminus of HIF-1α (amino acids 391-826) “markedly 
decreased the ability of recombinant HIF-1 [complex] to activate transcription” (Jiang 
et al., 1996). Within this HIF-1α molecule region, the carboxyl terminus contains an 
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oxygen-dependent degradation domain (ODD amino acids 401-613), N-terminal 
transactivation domain (NTAD amino acids 544-588), intervening inhibitory domain 
(ID amino acids 589-795) and a C-terminal transactivation domain (CTAD amino 
acids 796-836).  The alpha-F (alpha-helix F) which is seen in the dPER homodimer to 
be important for the formation of the dPER homodimer (Yildiz et al., 2005) is 
modelled before the amino acids 501-594 of the NPAS1. The alpha-F is seen in the 
dPER structure to bind to the PAS A domain of the chain B (2nd molecule of the 
homodimer). Since amino acids 501-594 is located carboxyl-terminal of the alpha-F, 
the possible significance of this region is to either further enhance the binding of the 
alpha-F region to the PAS A of the dimer partner. This clue offered by the structural 
model of NPAS1 based on dPER as a template. Alternatively, it might offer itself to 
bind other co-repressors with as yet unidentified trans- or cis- acting repression 
domains.  Present in the C-terminus (501-594) might also be an equivalent of the 
ODD in the HIF-1α. The body of knowledge on NPAS1 is still lacking in detail. 
Earlier studies (Teh et al., 2006) had identified NPAS1 as being upregulated by 
sodium butyrate added to the medium of MN9D cell culture. This might actually be a 
physiological environmental event, as butyrate is produced as a by-product from 
bacterial fermentation in the colon of TOS. However, the effect of butyrate might be 
short-lived (Atweh et al., 1999) and any significance of butyrate having an in vivo 
physiological effect on the NPAS1 molecule either at the transcriptional level or 
activation level is hypothetical and requires more rigorous testing.  
In vitro interaction between NPAS1 and ARNT  
Interaction between NPAS1 and ARNT was suspected as it is reported by Teh 
(2006) that ARNT and not ARNT2, when co-expressed with NPAS1, is able to 
repress TH (see Figure 15). At the time of writing, in vitro interaction between 
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NPAS1 and ARNT was only shown in one direction i.e. pulling down MBP tagged fl 
ARNT to pull down GST fl NPAS1. GST fl NPAS1 was able to pull down MBP fl 
ARNT in experiments conducted as well. However, in the control double 
transformants the MBP tag was pulled down by GST and GST fl NPAS1 (see Figure 
10). The difficulty in washing away the unspecific bindings could be that the level of 
expression of the shorter tags is higher than the longer tagged full-length proteins. In 
typical in vitro interaction studies, it is possible to adjust the ratio of protein 
concentrations by adjusting the lysate dilution. However, in this case, it is impossible 
to lower the concentration of the tag relative to the tagged full-length protein that is 
being co-expressed in the bacterial host. Nevertheless, MBP fl ARNT was not pulled 
down by GST (see Figure 10). 
 By the time the in vitro interaction between NPAS1 and ARNT was shown by 
the author, the finding became not entirely novel. Ohsawa et al. (2005) had beaten us 
to show that there is an in vivo interaction between NPAS1 and ARNT. In addition, in 
vivo interaction studies have also been done by Teh (2006). However, the present data 
still has novel value. The requirement for NPAS1 to be co-expressed with ARNT in 
the same bacterial host, in order for it to be competent to bind ARNT has not shown 
by others. This implicates ARNT as a possible molecular chaperone to ensure proper 
folding or to contribute to the stability of NPAS1 in the absence of eukaryotic factors. 
It is reported that ARNT promotes the stabilization of HIF-1α through a HSP90 
dependent pathway (Isaacs et al., 2004). Furthermore, the HSP90 binds PAS B of 
HIF-1α and this binding accelerates HIF-1α stabilization (Katschinski et al., 2004). 
All of these hint at a possibility that like HIF-1α, NPAS1 binds HSP90 as well. This 
hypothesis was tested when a search was conducted for in vivo interactors with 





Figure 15. Combined blots from (Teh, 2006) for overexpression studies with ARNT 
and ARNT2 in MN9D cells.   
Transient overexpression of GFP tagged NPAS1 with FLAG tagged ARNT caused 
the level of TH to be lowered as seen in this Western blot. ARNT2 in contrast had no 
such effect. 
 
Immunoprecipitation with FLAG tagged NPAS1 
In vivo pull down of HSP90, HSP70  
 One of the interactors with NPAS1 that was identified was heat shock 90kDa 
protein 1, beta (HSP90). Band FN1 (in the silver stained gel) and band 1 (in the 
Coomassie stained gel) were matched to HSP90. From the Coomassie gel in Figure 
12, FN1 was wrongly named as it not only binds the full-length and the N-terminus of 
NPAS1, it binds the C-terminus as well.  
After the initial difficulty in showing the in vitro binding of NPAS1 with 
ARNT, co-expression was attempted following the example of work done on HIF-1α 
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and ARNT (Chachami et al., 2005). The results hinted at a possible relationship 
between NPAS1 and HSP90. Several members of the basic helix-loop-helix 
(bHLH)/Per-ARNT-Sim domain (PAS) proteins including the dioxin receptor (AhR), 
hypoxia-inducible factors (HIF-1α HIF-2a HIF-3a) (Katschinski et al., 2004) and 
Drosophila single-minded (Sim1) (McGuire et al., 1995) bind HSP90. This 
interaction with HSP90 is hypothesized to be involved in the cellular localization of 
the bHLH PAS proteins like AhR (Kazlauskas et al., 2001). The binding is also 
thought to accelerate the stabilization of HIF-1α (Katschinski et al., 2004). The PAS 
B domain of HIF-1α, HIF-2a and HIF-3a is required for HSP90 interaction' 
(Katschinski et al., 2004). Furthermore, ARNT competed with HSP90 for binding to 
PAS B domain of HIF-1α (Katschinski et al., 2004). However, it seems that it not 
only PAS B binds HSP90, as amino acids 1-166 and 289-347 of murine AhR binds 
HSP90 (Perdew and Bradfield, 1996). As annotated in Swiss-Prot, the PAS A and 
PAS B domains of murine AhR are amino acids 116-179 and 269-336. This is 
consistent with the observation that both the N-terminus (1-354) and C-terminus (348-
594) binds HSP90 in the immunoprecipitation experiment (see Figure 12). Given that 
there are at least two bHLH PAS proteins which involve HSP90 in the stabilization 
and localisation of the bHLH PAS protein, it is not hard to imagine the same 
phenomena happening in NPAS1.  
Other than HSP90, HSP70 was one of the molecular chaperones that was 
pulled down. HSP70’s id name in the silver stained PAGE gel is FN4 and it is band 2 
in the Coomassie stained PAGE gel. Like HSP90, it was wrongly identified as 
binding specifically to the full-length and N-terminus of NPAS1 due to the numerous 
bands in the silver stained gel. HSP70 forms part of the HSP90 heterocomplex. Other 
members include the co-chaperone p23. HSP70 does not form a complex with all 
bHLH PAS proteins as evidenced by work done by Shetty et al. (2004). It was found 
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that another HSP90 associated protein CyP40 is required for the formation of the 
AhR-ARNT-DRE complex, not HSP70 (Shetty et al., 2004). The finding from the 
immunoprecipitation, that HSP70 associates with NPAS1 hints at a closer similarity 
between NPAS1 and HIF-1α than to AhR. More work, however, needs to be done to 
qualify this hypothesis that HSP70 is required for formation of an active complex 
which includes NPAS1. Both HSP70 and to a lesser extent, p23, is 
immunoprecipitated with HIF-1α from both hypoxic and normoxic HepG2 cell lysate 
(Katschinski et al., 2004). Interestingly the same group reported that although there is 
a lesser amount of HIF-1α in normoxic cells than in hypoxic cells, there is more 
HSP90 and HSP70 that is bound to HIF-1α precipitates. For the case of ARNT, the 
opposite is true where more of ARNT is found in HIF-1α precipitates from hypoxic 
cells compared to normoxic cells. This supports the view of a mutually exclusive 
binding of HSP90 or ARNT with HIF-1α (Katschinski et al., 2004). Since NPAS1 has 
been found to repress both EPO (Ohsawa et al., 2005) and TH (Teh, 2006), the author 
believes there is a possibility that NPAS1 is an antagonistic repressor of HIF-1α 
upregulated genes. It would be interesting therefore to repeat the experiments 
mentioned above by Katschinski et al. (2004) and use NPAS1 to pull down HSP90, 
HSP70 and ARNT in normoxic and hypoxic cells.  
ECP-51 / RuvB-like 2 protein 
The synonyms for ECP-51 are plenty: 48-kDa TATA box-binding protein-
interacting protein, 48-kDa TBP-interacting protein, 51 kDa erythrocyte cytosolic 
protein, CGI-46, ECP51, ECP-51, Repressing pontin 52, Reptin 52, RuvB-like 2, 
TAP54-beta, TIP48, TIP49b, TIP49B, TIP60-associated protein 54-beta and p47 in 
Mus musculus. It is named ECP-51 as it was isolated as a 51kDa erythrocyte cytosolic 
protein by affinity chromatography using a peptide of the integral membrane protein 
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stomatin as bait (Salzer et al., 1999). Therefore it may be present in the cytoplasm and 
associated with the cell membranes. It is however, mainly localized in the nucleus, 
and associated with the nuclear matrix or in the nuclear cytosol. ECP-51 appears to be 
a negative regulator of activating transcription factor 2 which is hypothesized to 
regulate the transcription of stress responsive genes (Cho et al., 2001).  
ECP-51 is also able to repress Pontin52 (Bauer et al., 2000) which is another 
nuclear protein which can interact with beta-catenin and TATA-box binding protein 
(TBP). ECP-51 is highly homologous to Pontin52 and is able to bind beta-catenin and 
TBP directly as well as being an interacting partner of Pontin52. Luciferase reporter 
gene assays in HEK293 cells done by the same group show that TIP49b represses 
gene activation mediated by T-cell factor (TCF)-beta-catenin thus behaving 
antagonistically to Pontin52. 
The finding that ECP-51 binds NPAS1 in vivo creates a link to the Wnt/beta-
catenin pathway. Butyrate is a histone deacetylase inhibitor like valproic acid (VPA) 
and Trichostatin A. The latter two are acknowledged to have much stronger effects 
than butyrate. VPA is used as a common anti-epileptic drug. However, VPA is known 
to cause spina bifida, a neural tube defect when it is given to pregnant mothers 
(Wiltse, 2005). Wnt signalling changes induced by VPA has been postulated, with 
supporting evidence, to be the cause of the developmental defects it brings about 
(Wiltse, 2005). Bearing in mind that those mice that are NPAS1 deficient appears to 
be normal compared to wild type mice in a variety of behavioural tests (Erbel-Sieler 
et al., 2004), it would be interesting to elucidate the cryptic role of NPAS1 in normal 
development. NPAS1/ NPAS3 double null mutant mice and to a lesser extent, NPAS3 
deficient mice display abnormal behaviour. It is possible that by virtue of its 50.2% 
similarity with NPAS3, NPAS1 is a paralog which duplicates the function served by 
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NPAS3. Therefore, it might be prudent to investigate NPAS3 along with NPAS1 in 
developmental studies. 
Tyrosine 3/tryptophan 5 -monooxygenase activation protein, epsilon 
polypeptide (gi|5803225) 
Tyrosine 3/tryptophan 5 -monooxygenase activation protein, epsilon 
polypeptide (gi|5803225) (abbreviated as TH activation protein) is another result 
which is immunoprecipitated by FLAG tagged NPAS1. The protein is a 14-3-3 
homolog, which are proteins that mediate signal transduction by binding to 
phosphoserine-containing proteins. They are also known to interact with MEK 
kinases. They are implicated in growth factor signalling (Bauer et al., 2005). 
TH activation protein is an activator protein that activates tryptophan 5-
monooxygenase and tyrosine 3-monooxygenase in the presence of Ca2+, calmodulin-
dependent protein kinase II (Ichimura et al., 1987; Yamauchi and Fujisawa, 1981). 
Tyrosine 3-monooxygenase or tyrosine hydroxylase (TH) is one of the enzymes that 
is required for the production of dopamine and noradrenalin. In addition it is the rate-
limiting enzyme for the production of dopamine neurotransmitter. Thus it is possible 
that tyrosine 3/tryptophan 5 -monooxygenase activation protein binds to NPAS1 in a 
manner to effect a negative feedback loop. Supporting evidence for the importance of 
TH activation protein to the function of NPAS1 comes from the fact that TH 
activation protein is found to be upregulated together with NPAS1 in butyrate treated 
MN9D cells (Teh et al., 2006). Since tyrosine 3/tryptophan 5 -monooxygenase 
activation protein requires the calmodulin-dependent protein kinase II and Ca2+ to 
activate tyrosine 3-monooxygenase, it is possible that these two factors maybe 
required to complete the feedback loop.  
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Modelling of the NPAS1 molecule using dPER as a template 
 Drosophila PERIOD protein's partial structure (PDB ID 1WA9) was used as a 
template to model the 3D structure of murine NPAS1. Three regions of the NPAS1 
molecule have been identified as having repression activity. They are NPAS1 71-165, 
NPAS1 206-290 and NPAS1 501-594. These three regions have consistently showed 
repressive activity in using beta-galactosidase in yeast and luciferase in HEK293 
cells. NPAS1 206-290 lies within the region of 201-244 where the dPER template 
cannot provide structural information. SWISS-MODEL depicted this region as a 
helical secondary structure which extends out (Figure 14). It appears that though the 
dPER structural data provides a useful template to model the 3D structural data of 
bHLH-PAS proteins, most parts of the regions identified as having repression activity 
is not duplicated in the dPER model. Part of the PAS A domain (141-165) of NPAS1 
is seen in the model to be similar in the PAS A beta sheet in dPER homodimer 
structure to be able to bind alpha-F of its dimer partner. As a result of not being able 
to clone the regions of 166-205, the possibility of PAS A being important for 
repression cannot be answered definitely. For the other two regions it can only be 
concluded that it is the variations of the bHLH-PAS proteins from the generic that 
results in its specific activity. The connector region between the PAS domains is not 
conserved between different bHLH-PAS proteins. However, for paralogs the 
similarity is higher i.e. NPAS3. This might be a result of paralogous events like gene 
duplication. Another region of interest is the C-terminus, which is not conserved 
across the different bHLH-PAS proteins as well. It is also another region namely 
amino acids 501-594, which has consistently showed repressive activity in two of the 
assays conducted. However, like the linker region, this region is not present in the 
dPER structural data hence, its function can only be guessed. The alpha-F helix in 
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dPER which is important for homodimerization, is replicated in the NPAS1 model. In 
the dPER homodimer structure, the alpha-F of the 2nd molecule (Chain B) is seen to 
associate with the PAS A domain of the 1st molecule (Chain A). The alpha-F of the 
2nd molecule is seen to have a sharp turn (kink) in its helical structure (see Figure 16). 
As it is not known if NPAS1 homodimerizes, the significance of the alpha-F helical 
secondary structure for NPAS1 repression activity is pure speculation. Therefore, 
NPAS1 was modelled after Chain A of dPER homodimer, which did not have a kink 
in its alpha-F. Considering the fact that the region when fused to an alien DNA 
binding domain does not confer repression activity, it can be hypothesized that 
repression activity is not dependent on NPAS1 homodimerization. This hypothesis is 
made under the assumption that the deletion clone (404-507) is folded correctly with 
respect to the native NPAS1 molecule, and the same region contains an alpha-F 
structure that is important for NPAS1 homodimerization.  
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Figure 16. View of dPER homodimer with emphasis on the kink in the alpha-F helix 
in the 2nd molecule.  
The alpha-F helices in both molecules are in red. The 1st molecule of the homodimer 
is in yellow, whilst the 2nd is in blue. The kink, which is indicated by the arrow, is 
more evident in this top down view. 
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5. Conclusion and future perspectives 
From the failure to label NPAS1 in the embryonic mice brain sections, it is 
possible that NPAS1 is expressed in low levels for the stages tested, and it is not 
specifically restricted to the embryonic brain only. Teh (2006) by using Western blot 
showed that indeed it is expressed in the midbrain and other tissues like liver.  
 NPAS1 71-165, NPAS1 206-290 and NPAS1 501-594 are the three deletion clones 
which have shown repressive ability consistently in both the beta-gal assay conducted 
in yeast and luciferase assay conducted in HEK293 cells. NPAS1 is not able to be 
expressed correctly in bacterial hosts, requiring co-expression of ARNT to make 
NPAS1 competent for binding with ARNT. This requirement for ARNT hints at a 
possible association of NPAS1 with HSP90 which is seen in other bHLH-PAS 
proteins as well. This was proven to be true as in mammalian cells HEK293, NPAS1 
binds HSP90 & HSP70 in immunoprecipitation experiments.  The former is likely to 
interact with NPAS1 in the same manner as HIF-1α and AhR and could possibly 
affect its localization in cytoplasm or in nucleus. 
 3D modelling of NPAS1 revealed that the regions of repression are mostly not 
duplicated in the structural data for dPER fragment. It is likely that these differing 
regions account for the specific effect of NPAS1. The absence of repressive activity 
data for the region of 166-205 amino acids only allows us to hazard that PAS A 
domain is important for repression. Based on the importance of alpha-F in the C-
terminus of dPER for homodimerization, this is highly probable. As part of the PAS A 
domain is shown in the dPER homodimer to bind the alpha-F (alpha helix F) of its 
dimer partner, it is possible that 501-594 amino acids of NPAS1 interacts with the 
PAS A domain of its dimer to enhance binding. Comparing to HIF-1α there are 
control elements in the C-terminus which are important for the transactivation activity 
 70 
of HIF-1α. It is possible as well that there are similar antagonistic motifs in this 
region. The mechanism for the repression effect of 206-290 amino acids of NPAS1 is 
not known.  
 Based on the identity of the in vivo interactors, it is possible that TH activation 
protein might bind NPAS1 to provide negative feedback to repress TH. It is possible 
that NPAS1 causes repression with the help of ECP-51, the other protein shown to 
immunoprecipitate with NPAS1. Since TH activation protein was identified as a 
NPAS1 interactor, it will be worthwhile to examine if it negatively regulates TH 
through an association with NPAS1. 
 Future experiments should be directed at mutagenesis of the putative regions 
of repression to show that the regions have physiological relevance in an in vivo 
context. Other bHLH-PAS interacting partners for NPAS1 could be tested as well, for 
example, ARNT2 and ARNT3/BMAL1. The latter is known to bind CLOCK. 
CLOCK-mice show increase in sensitivity to cocaine and excitability of dopaminergic 
neurons (McClung et al., 2005). It appears that absence of CLOCK there might lead 
to an increased TH expression. It is possible that the regulatory region of TH 
promoter receives input from the bHLH-PAS proteins CLOCK and NPAS1. Other 
dimerization partners may therefore modulate the effects of NPAS1 by the sharing of 
the pool of available generic dimer partners. The heterodimerization of NPAS1 with 
ARNT2 and ARNT3 might expand the repertoire of genes that NPAS1 represses i.e. it 
was found that co-expression of NPAS1 with ARNT2 did not repress TH (Teh, 2006), 
but it might have effects on other genes. 
Another worthwhile pursuit is to answer the question if NPAS1 is an 
antagonist of HIF-1α. EPO (Ohsawa et al., 2005) and TH are both genes reported to 
be upregulated by HIF-1α and now shown to be repressed by NPAS1. Microarray of 
genes regulated by NPAS1 would reveal more downstream genes regulated by 
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NPAS1 and answer this question. HIF-1α has been found to be important in 
regulating hypoxic responses of tumours (Amir et al., 2006). Histone deacetylase 
inhibitors like butyrate on the other hand have been targeted as anticancer drugs 
(Chen et al., 2003). Both HIF-1α and butyrate have a link with NPAS1, if NPAS1 is 
an antagonist of HIF-1α, then perhaps part of the therapeutic value of butyrate is due 
to the upregulation of NPAS1. The implications of a microarray study would thus 
have a definite effect in anti-cancer therapy.   
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Table I. The results of the quantitative beta-galactosidase experiments in yeast. 
Numbers are in the raw format.  
They have been normalized to their respective control ARNT(C) transactivation 
fusion and the results shown as a chart in Figure 4. The values for the fl NPAS1 and 
the N-terminus, C-terminus was only done for the last set of results hence they were 
not shown in Figure 4. 
 
NPAS1 1-70  4354.030584 2562.169052 10886.30362 
NPAS1 71-165 1496.175249 750.2964671 3571.427259 
NPAS1 206-290 1671.527399 1020.286741 3853.189179 
NPAS1 302-354 1315.39982 877.5499595 4050.651226 
NPAS1 348-403 1416.43535 869.1219699 4090.418422 
NPAS1 404-507 6758.127332 2753.023079 9073.332737 
NPAS1 501-594 1517.199765 577.7213291 3518.34851 
ARNT C CONTROL 3745.059305 1898.14033 14434.81818 
fl NPAS1 NA NA 5016.664442 
NPAS1 1-354 NA NA 4808.158502 





TARGET    146                                                      LDG 
1wa9A     237                                                      EDS 
                                                                    *. 
TARGET                                                                 
1wa9A                                                                  
 
 
TARGET    149   FVFALNQEG- KFLYISETVS IYLGLSQVEL TGSSVFDYIH PGDHSEVLEQ 
1wa9A     240   FCCVISMHDG IVLYTTPSIT DVLGYPRDMW LGRSFIDFVH LKDRATFASQ 
                *   ..       ** . ...   ** ..     * * .*..*   *..    * 
TARGET          ssssss     ssssss hhh hh              hhsss     hhhhhh 
1wa9A           ssssss     ssssss hhh hh              hh    h   hhhhhh 
 
 
TARGET    198   LGLRAASIGP PTPPSVSSSS SSSSSSLVDT PEIEASPTEA SPAFRAQERS 
1wa9A     290   IT-------- ---------- ---------- -TGIA----- -------KST 
                .                                    *               . 
TARGET                       hhhhhhhh      hhhhh hhhhhhhhh             
1wa9A                                                                  
 
 
TARGET    248   FFVRMKSTLT KRGLNVKASG YKVIHVTGRL RARALG---- -------LVA 
1wa9A     311   FCVMLRRYRG LKSGGFGVIG RPVSYEPFRL GLTFREAPEE ARSNGTNMLL 
                * * ..      ..      *   *     **                   ..  
TARGET          sssssss                  sssssss sssss              ss 
1wa9A           sssssss                  sssssss sssssss          ssss 
 
 
TARGET    287   LGHTLPPAPL AELPLHG--- --HMIVFRLS LGLTILACES RVSDHMDMGP 
1wa9A     367   VICATPIKSS YKVPDEILSQ KSPKFAIRHT ATGIISHVDS AAVSALGYLP 
                .  . *  .    .*          .. .* .     *   .*      .   * 
TARGET          sssss                     ssssss   sssssss  hhh        
1wa9A           sssssss         sss       ssssss   sssssss  hhh        
 
 
TARGET    332   SELVGRSCYQ FVHGQDATRI RQSHLDLLDK -----GQVVT GYYRWLQRAG 
1wa9A     417   QDLIGRSIMD FYHHEDLSVM KETYETVMKK GQTAGASFCS KPYRFLIQNG 
                 .*.***  . * * .* . . ...   .. *      .   .   ** * . * 
TARGET          hhh  sss         hhhh hhhhhhhhh         sss   sssss    




TARGET    377   GFVWLQSVAT VAGNGKSTGE HHVLWVSHVL SNAEGSQTPL DAFQLPAIVS 
1wa9A     467   CYVLLETEWT SFVNPWSRKL EFVVGHHRVF QGPKQCNVFE AAPTCKLKIS 
                 .* *..  *    *  *      *.   .*.   .         *      .* 
TARGET          ssssssssss ssss    ss ssssssssss                       
1wa9A             ssssssss ssss    ss ssssssssss ss                    
 
 
TARGET    427   QEEPSRPGPE PTEEEPPVDG KQAVPADQDK DKDPQARGKR IKVEASPKEA 
1wa9A     517   EEAQSRNTRI KEDIVKRLAE TVSRPSDTVK QEVSRRCQAL ASFMETLMDE 
                .*  **       .    .     . *.*  * .  ..           . ..  
TARGET                hhhh hhhhh   h           h hhhhhhhhhh hhhhhhhhhh 
1wa9A                h   h hhhhh   h           h hhh   hhhh hhhhhhhhhh 
 
 
TARGET    477   RGSED                                                  
1wa9A     567   VSRAD-                                                 
                 .  *                                                  
TARGET          hhhh                                                   
1wa9A           hhh     
 
Figure I. Alignment of the NPAS1 molecule with dPER from the PDB file that is 
predicted by the SWISS-MODEL server. 
Only amino acids 146-481 of the NPAS1 molecule is aligned to the dPER fragment 
(amino acids 232 to 599). Target refers to NPAS1, 1wa9A refers to dPER (Chain A). 
The letters h refers to alpha helix secondary structure and s refers to beta sheet 
secondary structure. 
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Table II. The raw luminometer readings for MN9D cells.  
The RLU values are very close to the machine background, which averages 13 
RLU/s. 
  Firefly RLU/s added stop and glo 
NPAS1 1-70  14 29 
NPAS1 1-70  18 44 
NPAS1 1-70  21 44 
NPAS1 1-70  16 51 
NPAS1 71-165 18 68 
NPAS1 71-165 16 39 
NPAS1 71-165 13 35 
NPAS1 71-165 21 35 
NPAS1 206-290 27 47 
NPAS1 206-290 41 70 
NPAS1 206-290 19 47 
NPAS1 206-290 15 35 
NPAS1 302-354 27 52 
NPAS1 302-355 29 47 
NPAS1 302-356 29 42 
NPAS1 302-357 12 34 
NPAS1 348-403 17 48 
NPAS1 348-404 19 28 
NPAS1 348-405 59 32 
NPAS1 348-406 13 30 
NPAS1 404-507 43 86 
NPAS1 404-508 69 124 
NPAS1 404-509 52 90 
NPAS1 404-510 89 101 
NPAS1 501-594 30 67 
NPAS1 501-595 31 77 
NPAS1 501-596 29 96 
NPAS1 501-597 31 77 
pM_1 39 131 
pM_2 162 95 
pM_3 44 79 
pM_4 34 103 
 
